<SEC-DOCUMENT>0001193125-23-232599.txt : 20230911
<SEC-HEADER>0001193125-23-232599.hdr.sgml : 20230911
<ACCEPTANCE-DATETIME>20230911172300
ACCESSION NUMBER:		0001193125-23-232599
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230905
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230911
DATE AS OF CHANGE:		20230911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEGALZOOM.COM, INC.
		CENTRAL INDEX KEY:			0001286139
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				954752856
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35618
		FILM NUMBER:		231248518

	BUSINESS ADDRESS:	
		STREET 1:		101 N. BRAND BLVD., SUITE 1100
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		323-962-8600

	MAIL ADDRESS:	
		STREET 1:		101 N. BRAND BLVD., SUITE 1100
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEGALZOOM COM INC
		DATE OF NAME CHANGE:	20040405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d485281d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lz="http://leg.com/20230905" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-09-05_to_2023-09-05">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-09-05_to_2023-09-05">0001286139</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="lz-20230905.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-09-05_to_2023-09-05"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001286139</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-05</xbrli:startDate> <xbrli:endDate>2023-09-05</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-09-05_to_2023-09-05">8-K</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt:datemonthdayyearen">September 5, 2023</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-09-05_to_2023-09-05">LegalZoom.com, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-09-05_to_2023-09-05">001-35618</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-09-05_to_2023-09-05">95-4752856</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-09-05_to_2023-09-05">101 North Brand Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-09-05_to_2023-09-05">11th Floor</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-09-05_to_2023-09-05">Glendale</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-09-05_to_2023-09-05">91203</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-09-05_to_2023-09-05">(323)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-09-05_to_2023-09-05">962-8600</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-09-05_to_2023-09-05">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-09-05_to_2023-09-05">LZ</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-09-05_to_2023-09-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;1.01 Entry into a Material Definitive Agreement. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;5, 2023, LegalZoom.com, Inc. (the &#8220;Company&#8221;) entered into a Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with LucasZoom, LLC (the &#8220;Selling Stockholder&#8221;). On September&#160;11, 2023, pursuant to the Purchase Agreement and substantially concurrently with the closing of the Secondary Offering (as defined below), the Company repurchased 4,718,755 shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), for an aggregate purchase price of approximately $45.1&#160;million directly from the Selling Stockholder in a private, <span style="white-space:nowrap">non-underwritten</span> transaction (the &#8220;Stock Repurchase&#8221;), at a price per share of $9.55, which is equal to the price paid by the Underwriters (as defined below) to the Selling Stockholder in the Secondary Offering. The Stock Repurchase was funded from cash on hand and was part of the Company&#8217;s existing share repurchase program. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Purchase Agreement is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;8.01 Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;6, 2023, the Company entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) among the Company, J.P. Morgan Securities LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;), and the Selling Stockholder in connection with the underwritten public offering by the Selling Stockholder of 14,000,000 shares of Common Stock at a public offering price of $10.00 per share (the &#8220;Secondary Offering&#8221;). In connection with the Secondary Offering, the Selling Stockholder granted the Underwriters a <span style="white-space:nowrap">30-day</span> option to purchase up to an additional 2,100,000 shares of Common Stock.&#160;The Company did not offer any shares of Common Stock in the Secondary Offering and did not receive any proceeds from the sale of shares of Common Stock in the Secondary Offering. On September&#160;8, 2023, the Underwriters notified the Company and the Selling Stockholder of their intent to exercise their option to purchase the additional 2,100,000 shares in full. The Secondary Offering closed on September&#160;11, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Secondary Offering was made pursuant to a prospectus supplement, dated September&#160;6, 2023, to the prospectus, dated September&#160;6, 2023, which was included in the Company&#8217;s shelf registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-274367)</span> filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on September&#160;6, 2023, and which became effective upon filing with the Commission. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains the terms and conditions for the sale by the Selling Stockholder of the shares of Common Stock to the Underwriters, customary representations, warranties and agreements by the Company and Selling Stockholder, customary conditions to closing, indemnification obligations of each party to the Underwriting Agreement, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01 Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Exhibits</span>. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit</span> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d485281dex11.htm">Underwriting Agreement, dated as of September&#160;6, 2023, among the Company, J.P. Morgan Securities LLC and the Selling Stockholder. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d485281dex101.htm">Stock Purchase Agreement, dated September&#160;5, 2023, between the Company and the Selling Stockholder. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">LegalZoom.com, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: September&#160;11, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Noel Watson</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">Noel Watson</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">Chief Financial Officer</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-style:italic">(Principal Financial and Accounting Officer)</span></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d485281dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Execution Version </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LEGALZOOM.COM, INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14,000,000
Shares of Common Stock, par value $0.001 per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Underwriting Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">September&nbsp;6, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(As Representative of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;several Underwriters listed </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;in Schedule 1 hereto) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan
Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and
Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder named in Schedule 2 hereto (the &#147;Selling Stockholder&#148;) of LegalZoom.com, Inc., a Delaware
corporation (the &#147;Company&#148;), proposes to sell to the several underwriters listed in Schedule 1 hereto (the &#147;Underwriters&#148;), for whom you are acting as representative (the &#147;Representative&#148;), an aggregate of 14,000,000
shares of common stock, par value $0.001 per share, of the Company (the &#147;Underwritten Shares&#148;), and, at the option of the Underwriters, up to an additional 2,100,000 shares of common stock, par value $0.001 per share, of the Company (the
&#147;Option Shares&#148;). The Underwritten Shares and the Option Shares are herein referred to as the &#147;Shares&#148;. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to
herein as the &#147;Stock&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the Selling Stockholder hereby confirm their agreement with the several Underwriters
concerning the purchase and sale of the Shares, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The Company has prepared and filed with the
Securities and Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), a registration statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-274367),</FONT> including a prospectus, relating to the Shares. Such registration statement, as amended at the time it became effective, including the
information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness (&#147;Rule 430 Information&#148;), is referred to herein as the &#147;Registration
Statement&#148;; and as used herein, the term &#147;Preliminary Prospectus&#148; means each prospectus included or incorporated by reference in such registration statement (and any amendments thereto) before effectiveness, any prospectus filed with
the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430 Information, and the term &#147;Prospectus&#148; means the prospectus in
the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule
462(b) under the Securities Act (the &#147;Rule&nbsp;462 Registration Statement&#148;), then any reference herein to the term &#147;Registration Statement&#148; shall be deemed to include such Rule 462 Registration Statement. Any reference in this
underwriting agreement (this &#147;Agreement&#148;) to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#147;amend&#148;,
&#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of
1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Exchange Act&#148;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings
given to such terms in the Registration Statement and the Prospectus. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the Applicable Time (as defined below), the Company had prepared the
following information (collectively with the pricing information set forth on Annex A, the &#147;Pricing Disclosure Package&#148;): a Preliminary Prospectus dated September&nbsp;6, 2023 and each &#147;free-writing prospectus&#148; (as defined
pursuant to Rule 405 under the Securities Act) listed on Annex A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Applicable Time&#148; means 7:20 P.M., New York City time,
on September&nbsp;6, 2023. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Shares</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Selling Stockholder agrees to sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of $9.55 (the &#147;Purchase
Price&#148;) from the Selling Stockholder the number of Underwritten Shares (to be adjusted by the Representative so as to eliminate fractional shares) determined by multiplying the aggregate number of Underwritten Shares to be sold by the Selling
Stockholder as set forth opposite its name in Schedule 2 hereto by a fraction, the numerator of which is the aggregate number of Underwritten Shares to be purchased by such Underwriter as set forth opposite the name of such Underwriter in Schedule 1
hereto (as such number may be increased as set forth in Section&nbsp;12 hereof) and the denominator of which is the aggregate number of Underwritten Shares to be purchased by all the Underwriters from the Selling Stockholder hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Selling Stockholder agrees, to the extent indicated in Schedule 2 hereto, to sell the Option Shares to the several
Underwriters and the Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not jointly, from the Selling
Stockholder the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares
which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (as such number may be increased as set forth in
Section&nbsp;12 hereof) bears to the aggregate number of Underwritten Shares being purchased from the Selling Stockholder by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Shares as the Representative in
its sole discretion shall make. Any such election to purchase Option Shares shall be made in proportion to the maximum number of Option Shares to be sold by the Selling Stockholder as set forth in Schedule 2 hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the
thirtieth day following the date of the Prospectus, by written notice from the Representative to the Company and the Selling Stockholder. Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and
the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as
hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section&nbsp;12 hereof). Any such notice shall be given at least two business days prior to the date and time of
delivery specified therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Selling Stockholder understands that the Underwriters intend to make a public offering of the Shares,
and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Selling Stockholder acknowledges and agrees that the Underwriters may offer and sell Shares to or through any affiliate of an Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for the Shares shall be made by wire transfer in immediately available funds to the accounts specified by the Selling Stockholder
to the Representative in the case of the Underwritten Shares, at the offices of Latham&nbsp;&amp; Watkins LLP, 140 Scott Drive, Menlo Park, California 94025, at 10:00 A.M. New York City time on September&nbsp;11, 2023, or at such other time or place
on the same or such other date, not later than the fifth business day thereafter, as the Representative and the Selling Stockholder may agree upon in writing or, in the case </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Option Shares, on the date and at the time and place specified by the Representative in the written notice of the Underwriters&#146; election to purchase such Option Shares. The time and
date of such payment for the Underwritten Shares is referred to herein as the &#147;Closing Date&#148;, and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#147;Additional
Closing Date&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall
be made against delivery to the Representative for the respective accounts of the several Underwriters of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with
the sale of such Shares duly paid by the Selling Stockholder. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&#147;DTC&#148;) unless the Representative shall otherwise instruct. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each of the Company and the Selling Stockholder acknowledges and agrees that the Representative and the other Underwriters are acting
solely in the capacity of an arm&#146;s length contractual counterparty to the Company and the Selling Stockholder with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering of
Shares contemplated hereby) and not as a financial advisor or a fiduciary to, or an agent of, the Company, the Selling Stockholder or any other person. Additionally, neither the Representative nor any other Underwriter is advising the Company, the
Selling Stockholder or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Selling Stockholder shall consult with their own advisors concerning such matters and each shall be
responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representative nor any other Underwriter shall have any responsibility or liability to the Company or the Selling
Stockholder with respect thereto. Any review by the Representative and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the
Representative and the other Underwriters and shall not be on behalf of the Company or the Selling Stockholder. Moreover, the Selling Stockholder acknowledges and agrees that, although the Representative may be required or choose to provide the
Selling Stockholder with certain Regulation Best Interest and Form CRS disclosures in connection with the offering, the Representative and the other Underwriters are not making a recommendation to the Selling Stockholder to participate in the
offering, enter into a <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement, or sell any Shares at the price determined in the offering, and nothing set forth in such disclosures is intended to suggest that the Representative or any
Underwriter is making such a recommendation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of the Company</U>. The Company represents and warrants
to each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Preliminary Prospectus.</I> No order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the applicable requirements of the Securities Act, and no
Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with the Underwriter
Information (as defined in Section&nbsp;9(c) of this Agreement) or the Selling Stockholder Information (as defined in Section&nbsp;4(e) of this Agreement). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Pricing Disclosure Package</I>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing
Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with the Underwriter Information or the Selling
Stockholder Information. No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to be included in
the Prospectus has been omitted therefrom. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Issuer Free Writing Prospectus. </I>Other than the Registration
Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not
prepare, make, use, authorize, approve or refer to any &#147;written communication&#148; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication by
the Company or its agents and representatives (other than a communication referred to in clause (i)&nbsp;below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not constituting a prospectus pursuant to
Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii)&nbsp;the documents listed on Annex A hereto, each electronic road show and any other written communications approved in writing in advance by the
Representative, such approval not to be unreasonably withheld or delayed. Each such Issuer Free Writing Prospectus, if any, complies in all material respects with the applicable provisions of the Securities Act, has been or will be (within the time
period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and does not conflict with the information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together
with the Preliminary Prospectus accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation
or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with the Underwriter Information or the Selling Stockholder Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Materials. </I>The
Company (i)&nbsp;has not alone engaged in any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications and (ii)&nbsp;has not authorized anyone other than the Representative to engage in <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications (as defined below). The Company reconfirms that the Representative has been authorized to act on its behalf in undertaking <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications by virtue of a writing substantially in the form of Exhibit A hereto.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Testing-the-Waters</FONT></FONT> Communication&#148; means any oral or written communication with potential investors undertaken in reliance on either Section&nbsp;5(d) of, or
Rule 163B under, the Securities Act. The Company has not distributed or approved for distribution any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications other than those listed
on Annex B hereto. &#147;Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication&#148; means any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written communication within the meaning of Rule 405 under the Securities Act. Any individual Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication prepared or authorized by the Company does not conflict with the information contained in the Registration Statement or the Pricing Disclosure
Package, complied in all material respects with the applicable provisions of the Securities Act, and when taken together with the Pricing Disclosure Package as of the Applicable Time, did not, and as of the Closing Date and as of the Additional
Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading <U>provided</U> that the Company makes no representation and warranty with respect to any statements or omissions made in each such Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-The-Waters</FONT></FONT>
Communications in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in such Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-The-Waters</FONT></FONT> Communication, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;9(c) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Registration Statement and Prospectus</I>. The Registration Statement is an &#147;automatic shelf registration
statement&#148; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement or
any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission, and no proceeding for
that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering of the Shares has been initiated or, to the knowledge of the Company, threatened by the Commission; as of the applicable effective date
of the Registration Statement and any post-effective amendment thereto, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Registration Statement and any such post-effective amendment complied and will comply in all material respects with the applicable provisions of the Securities Act, and did not and will not as of
the applicable effective date contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus
and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the applicable provisions of the Securities Act and will not
contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes
no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with the Underwriter Information or the Selling Stockholder Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Incorporated Documents</I>. The documents incorporated by reference in the Registration Statement, the Prospectus and
the Pricing Disclosure Package, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained any untrue statement of a material fact or omitted to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Registration Statement, the Prospectus or
the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Financial Statements.</I> The financial statements (including the related notes thereto) of the Company and its
consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange
Act, as applicable, and present fairly in all material respects the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods
specified; such financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#147;GAAP&#148;) applied on a consistent basis throughout the periods covered thereby (except in the case of
unaudited financial statements, which are subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and do not contain certain footnotes as permitted by applicable rules of the Commission), and any supporting schedules included
or incorporated by reference in the Registration Statement present fairly in all material respects the information required to be stated therein; and the other financial information included or incorporated by reference in the Registration
Statement, the Pricing Disclosure Package and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly in all material respects the information shown thereby; all disclosures
included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding <FONT STYLE="white-space:nowrap">&#147;non-GAAP</FONT> financial measures&#148; (as such term is defined by the rules
and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> of the Securities Act, to the extent applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>No Material Adverse Change.</I> Since the date of the most recent financial statements of the Company included or
incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i)&nbsp;except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there has not been any change
in the capital stock (other than the issuance of shares of Stock upon exercise or settlement (including any &#147;net&#148; or &#147;cashless&#148; exercises or settlements) of stock options, restricted stock units and warrants described as
outstanding in, and the grant of options, restricted stock units and awards under existing equity incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus, and the repurchase of shares of capital
stock pursuant to agreements providing for an option or obligation to repurchase or a right of first refusal on behalf of the Company pursuant to the Company&#146;s repurchase rights), any change in short-term debt or long-term debt of the Company
or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, management, financial position, stockholders&#146; equity, or results
of operations or prospects of the Company and its subsidiaries taken as a whole; (ii)&nbsp;except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries has
entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to
the Company and its subsidiaries taken as a whole; and (iii)&nbsp;neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company taken as a whole and that is either from fire,
explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise
disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Organization and Good
Standing.</I> The Company and each of its significant subsidiaries have been duly organized and are validly existing and in good standing (to the extent that the concept of &#147;good standing&#148; is applicable under the laws of such jurisdiction)
under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing (to the extent that the concept of &#147;good standing&#148; is applicable under the laws of such jurisdiction) in each
jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the
businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties,
management, consolidated financial position, consolidated stockholders&#146; equity, consolidated results of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under
this Agreement (a &#147;Material Adverse Effect&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Capitalization.</I> The Company has an authorized
capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#147;Description of Capital Stock&#148;; all the outstanding shares of capital stock of the Company (including the Shares
to be sold by the Selling Stockholder) have been duly authorized and validly issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and are not subject to any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> or
similar rights that have not been duly waived or satisfied; except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding rights (including, without
limitation, <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its
subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights,
warrants or options; the capital stock of the Company conforms in all material respects to the description thereof contained in the section titled &#147;Description of Capital Stock&#148; in the Registration Statement, the Pricing Disclosure Package
and the Prospectus; and, except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, all the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by
the Company have been duly and validly authorized and issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except, in the case of any foreign subsidiary, for directors&#146; qualifying shares) and are owned directly or
indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Stock Options. </I>With respect to the stock options (the &#147;Stock Options&#148;) granted pursuant to the stock-based
compensation plans of the Company and its subsidiaries (the &#147;Company Stock Plans&#148;), except as would not reasonably be expected to have a Material Adverse Effect, (i)&nbsp;each Stock Option intended to qualify as an &#147;incentive stock
option&#148; under Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) so qualifies, (ii)&nbsp;each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was
by its terms to be effective (the &#147;Grant Date&#148;) by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if
any) was duly executed and delivered by each party thereto, (iii)&nbsp;each such grant was made in accordance with the terms of the Company Stock Plans and all other applicable laws and regulatory rules or requirements, including the rules of the
Nasdaq Global Select Market (the &#147;Nasdaq Market&#148;) and any other exchange on which Company securities are traded and (iv)&nbsp;each such grant was properly accounted for in accordance with GAAP in the financial statements (including the
related notes) of the Company and disclosed in the Company&#146;s filings with the Commission in accordance with the Exchange Act and all other applicable laws. The Company has not knowingly granted, and there is no and has been no policy or
practice of the Company of granting, Stock Options immediately prior to, or otherwise coordinating the grant of Stock Options with, the release or other public announcement of material information regarding the Company or its subsidiaries or their
results of operations or prospects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Due Authorization.</I> The Company has full corporate right, power and
authority to execute and deliver this Agreement and to perform its obligations hereunder; and all corporate action required to be taken by the Company for the due and proper authorization, execution and delivery by it of this Agreement and the
consummation by it of the transactions contemplated hereby has been duly and validly taken. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Underwriting Agreement.
</I>This Agreement has been duly authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) [<I>Reserved.</I>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>No Violation or Default.</I> Neither the Company nor any of its significant subsidiaries is (i)&nbsp;in violation of its
charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or
observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in violation of any applicable law or statute or any judgment, order, rule or regulation of any court or arbitrator or
governmental or regulatory authority having jurisdiction over the Company or any of its subsidiaries, except, in the case of clauses (ii)&nbsp;and (iii) above, and with respect to the Company&#146;s subsidiaries in the case of clause (i)&nbsp;above,
for any such default or violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>No Conflicts. </I>The execution, delivery and performance by the Company of this Agreement and the consummation of the
transactions contemplated by this Agreement or the Pricing Disclosure Package and the Prospectus will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the
termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust,
loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries
is subject, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents of the Company or any of its subsidiaries or (iii)&nbsp;result in the violation of
any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, having jurisdiction over the Company, except, in the case of clauses (i)&nbsp;and (iii) above, for any such conflict,
breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>No Consents Required.</I> No consent, approval, authorization, order, registration or qualification of or with any court
or arbitrator or governmental or regulatory authority is required to be obtained by the Company for the execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated by this Agreement,
except for the registration of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by the Financial Industry Regulatory Authority, Inc.
(&#147;FINRA&#148;), the Nasdaq Market and under applicable state securities laws in connection with the purchase and distribution of the Shares by the Underwriters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>Legal Proceedings.</I> Except as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#147;Actions&#148;) pending to which the Company or any of its subsidiaries is a party or to which
any property of the Company or any of its subsidiaries is the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, would reasonably be expected to have a Material Adverse Effect; no such
Actions are threatened or, to the knowledge of the Company, contemplated by any governmental or regulatory authority or threatened by others that would reasonably be expected to have a Material Adverse Effect; and (i)&nbsp;there are no current or
pending Actions that are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement, the Pricing Disclosure Package and
the Prospectus and (ii)&nbsp;there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing
Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <I>Independent Accountants</I>. PricewaterhouseCoopers LLP, who have certified certain financial statements of the Company
and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board
(United States) and as required by the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Title to Real and Personal Property</I>. The Company and its
subsidiaries have good and marketable title in fee simple (in the case of real property) to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and
its subsidiaries taken as a whole (other than with respect to Intellectual Property, title to which is addressed exclusively in subsection (u)), in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title
except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or (ii)&nbsp;could not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <I>Intellectual Property.</I> Except as would not reasonably be expected to have a Material Adverse
Effect, (i)&nbsp;to the knowledge of the Company, the Company and its subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain
names and other source indicators, copyrights and copyrightable works, <FONT STYLE="white-space:nowrap">know-how,</FONT> trade secrets, systems, procedures, proprietary or confidential information and all other worldwide intellectual property,
industrial property and proprietary rights (collectively, &#147;Intellectual Property&#148;) used in the conduct of their respective businesses; (ii)&nbsp;to the knowledge of the Company, the Company&#146;s and its subsidiaries&#146; conduct of
their respective businesses does not infringe, misappropriate or otherwise violate any Intellectual Property of any person; (iii)&nbsp;the Company and its subsidiaries have not received any notice of any claim relating to the infringement,
misappropriation, or violation of any third party&#146;s Intellectual Property; and (iv)&nbsp;to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being infringed, misappropriated or otherwise
violated by any person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>No Undisclosed Relationships</I>. No relationship, direct or indirect, exists between or
among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be
described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Investment Company Act</I>. The Company is not required to register
as an &#147;investment company&#148; or an entity &#147;controlled&#148; by an &#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder
(collectively, the &#147;Investment Company Act&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <I>Taxes.</I> The Company and its subsidiaries have paid all
U.S. federal, state, local and foreign taxes and filed all tax returns required to be paid or filed through the date hereof, except where the failure to pay or file would not reasonably be expected to have a Material Adverse Effect; and except as
otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus or as would not reasonably be expected to have a Material Adverse Effect, there is no tax deficiency that has been, or would reasonably be
expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <I>Licenses and Permits.</I> The Company and its subsidiaries possess all licenses,
<FONT STYLE="white-space:nowrap">sub-licenses,</FONT> certificates, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities
that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the
failure to possess or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and except as described in each of the Registration Statement, the Pricing Disclosure Package and the
Prospectus, or as would not reasonably be expected to have a Material Adverse Effect, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license,
<FONT STYLE="white-space:nowrap">sub-license,</FONT> certificate, permit or authorization or has any reason to believe that any such license, <FONT STYLE="white-space:nowrap">sub-license,</FONT> certificate, permit or authorization will not be
renewed in the ordinary course. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>No Labor Disputes.</I> No labor disturbance by employees of the Company or any of
its subsidiaries or labor dispute between the Company or any of its subsidiaries and its or their employees exists or, to the knowledge of the Company, is contemplated or threatened, except as would not reasonably be expected to have a Material
Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>Certain Environmental Matters</I>. (i)&nbsp;The Company and its subsidiaries (x)&nbsp;are in
compliance with all, and have not violated any, applicable federal, state, local and foreign laws (including common law), rules, regulations, requirements, decisions, judgments, decrees, orders and other legally enforceable requirements relating to
pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#147;Environmental Laws&#148;); (y) have received and are in compliance
with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z)&nbsp;have not received notice of any actual or
potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants
or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice, and (ii)&nbsp;there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its
subsidiaries, except in the case of each of (i)&nbsp;and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iii)&nbsp;except as described in each of the
Pricing Disclosure Package and the Prospectus, the Company has not received notice of any proceedings that are pending, or that is known to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a
governmental entity is also a party, other than such proceeding regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, (y)&nbsp;the Company and its subsidiaries are not aware of any facts or issues
regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that could reasonably be expected to have a material effect
on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z)&nbsp;none of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Company or its subsidiaries anticipates material capital expenditures relating to any Environmental Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>Compliance with ERISA</I>. (i)&nbsp;Each employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee
Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), for which the Company or any member of its &#147;Controlled Group&#148; (defined as any entity, whether or not incorporated, that is under common control with the Company within
the meaning of Section&nbsp;4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section&nbsp;414(b),(c),(m) or (o)&nbsp;of the Code) would have any liability (each, a &#147;Plan&#148;) has been
maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii)&nbsp;no prohibited transaction, within the meaning of Section&nbsp;406 of
ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii)&nbsp;for each Plan that is subject to the funding rules of Section&nbsp;412 of
the Code or Section&nbsp;302 of ERISA, no Plan has failed (whether or not waived), and, as of the date hereof, the Company has no knowledge that any such event is reasonably expected to fail, to satisfy the minimum funding standards (within the
meaning of Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code) applicable to such Plan; (iv)&nbsp;no Plan is, or is reasonably expected to be, in &#147;at risk status&#148; (within the meaning of Section&nbsp;303(i) of ERISA) and no Plan that
is a &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA is in &#147;endangered status&#148; or &#147;critical status&#148; (within the meaning of Sections 304 and 305 of ERISA)&nbsp;(v) the fair market value of the
assets of each Plan equals or exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (vi) no &#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c) of ERISA
and the regulations promulgated thereunder) has occurred and, as of the date hereof, the Company has no knowledge that any such event is reasonably expected to occur; (vii)&nbsp;each Plan that is intended to be qualified under Section&nbsp;401(a) of
the Code has received a favorable determination letter (or opinion letter, if applicable) as to its qualified status under the Code and, to the knowledge of the Company, nothing has occurred, whether by action or by failure to act, which would
impact such favorable determination letter (or opinion letter, if applicable); (viii) neither the Company nor any member of the Controlled Group has incurred, nor, as of the date hereof, does the Company reasonably expect any such party to incur,
any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guarantee Corporation, in the ordinary course and without default) in respect of a Plan (including a &#147;multiemployer plan&#148; within
the meaning of Section&nbsp;4001(a)(3) of ERISA); and (ix)&nbsp;none of the following events has occurred and, as of the date hereof, the Company has no knowledge that any of the following events is reasonably likely to occur: (A)&nbsp;a material
increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such
contributions made in the Company&#146;s and its Controlled Group affiliates&#146; most recently completed fiscal year; or (B)&nbsp;a material increase in the Company and its subsidiaries&#146; &#147;accumulated post-retirement benefit
obligations&#148; (within the meaning of Accounting Standards Codification Topic <FONT STYLE="white-space:nowrap">715-60)</FONT> compared to the amount of such obligations in the Company and its subsidiaries&#146; most recently completed fiscal
year, except in each case with respect to the events or conditions set forth in (i)&nbsp;through (ix) hereof, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>Disclosure Controls</I>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, the Company and its subsidiaries maintain an effective system of &#147;disclosure controls and procedures&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> of the Exchange Act) that complies with the
requirements of the Exchange Act applicable to the Company and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the Commission&#146;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#146;s management as appropriate to
allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT>
of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>Accounting Controls.</I> The Company and its subsidiaries taken as a
whole maintain systems of &#147;internal control over financial reporting&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) that have been designed to comply with the requirements of the Exchange Act
applicable to the Company and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company and its subsidiaries taken as a whole maintain internal accounting controls sufficient to provide reasonable
assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to
maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences and (v)&nbsp;interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus and the Pricing
Disclosure Package fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. Except as disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, the Company is not aware of any material weaknesses in the Company&#146;s internal controls over financial reporting, based on the Company and/or its subsidiary&#146;s most recent evaluation of its internal
controls over financial reporting pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(c)</FONT> of the Exchange Act. The Company&#146;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of:
(x)&nbsp;all significant deficiencies and material weaknesses, if any, in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Company&#146;s ability to
record, process, summarize and report financial information; and (y)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal controls over financial reporting.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>eXtensible Business Reporting Language.</I> The interactive data in eXtensible Business Reporting Language
included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <I>Insurance. </I>Except as would not reasonably be expected to have a Material Adverse Effect, the Company and its
subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks that the Company reasonably
believes are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i)&nbsp;received notice from any insurer or agent of such insurer that capital improvements
or other expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg)
<I>Cybersecurity; Data Protection. </I>Except as would not reasonably be expected to have a Material Adverse Effect, (A)&nbsp;the Company and its subsidiaries&#146; information technology assets and equipment, computers, systems, networks, hardware,
software, websites, applications, and databases (collectively, &#147;IT Systems&#148;) are designed to be adequate for, and designed to operate and perform, in all respects, as required in connection with, the operation of the business of the
Company and its subsidiaries as currently conducted, and (B)&nbsp;to the knowledge of the Company, all IT Systems are free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its
subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards designed to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and
security of their IT Systems and data (including all personal and personally identifiable data (&#147;Personal Data&#148;)) used by the Company or its subsidiaries in connection with their businesses. Except as would not reasonably be expected to
have a Material Adverse Effect, and to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
knowledge of the Company, there have been no breaches, violations or unauthorized uses of or accesses to IT Systems and Personal Data, except for those that have been remedied without cost or
liability or the mandatory legal duty to notify any other person, nor are any such incidents under internal review or investigation as of the date hereof. Except as would not reasonably be expected to have a Material Adverse Effect, the Company and
its subsidiaries are presently in compliance with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations to which the Company and its subsidiaries are bound relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or
modification. The Company and its subsidiaries have taken all commercially reasonable actions designed to comply with the European Union General Data Protection Regulation to the extent applicable to the Company or its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <I>No Unlawful Payments.</I> Neither the Company nor any of its subsidiaries nor any director or officer of the Company or
any of its subsidiaries nor, to the knowledge of the Company, any employee of the Company or any of its subsidiaries nor any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has
(i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization of any direct or
indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on
behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii)&nbsp;violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or
regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or
anti-corruption law; or (iv)&nbsp;made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any improper rebate, payoff, influence payment, kickback or other
unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintained and enforced, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable
anti-bribery and anti-corruption laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Compliance with Anti-Money Laundering Laws</I>. The operations of the
Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the
applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any applicable related or similar rules, regulations or guidelines issued,
administered or enforced by any governmental agency (collectively, the &#147;Anti-Money Laundering Laws&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <I>No Conflicts with Sanctions Laws. </I>Neither the Company nor any of its subsidiaries, directors or officers, nor, to
the knowledge of the Company, any employee of the Company or any of its subsidiaries nor any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is or is owned or controlled by one or more
persons that are currently the subject or the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;OFAC&#148;) or
the U.S. Department of State and including, without limitation, the designation as a &#147;specially designated national&#148; or &#147;blocked person&#148;), the United Nations Security Council (&#147;UNSC&#148;), the European Union, His
Majesty&#146;s Treasury (&#147;HMT&#148;) or other relevant sanctions authority (collectively, &#147;Sanctions&#148;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or
target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria, the Crimea Region of Ukraine, the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, the
<FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic and any other Covered </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Region of Ukraine identified pursuant to Executive Order 14065 (each, a &#147;Sanctioned Country&#148;). For the past five years, neither the Company nor any of its subsidiaries, directors,
officers, or employees, nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is or is owned or controlled by one or more persons knowingly engaged in
any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <I>No Restrictions on Subsidiaries</I>. Except as described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other
distribution on such subsidiary&#146;s capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#146;s properties or assets to the
Company or any other subsidiary of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <I>No Broker&#146;s Fees.</I> Neither the Company nor any of its
subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Underwriter for a brokerage commission, finder&#146;s fee or like
payment in connection with the offering and sale of the Shares by the Selling Stockholder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <I>No Registration
Rights</I>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and except for such rights as have been duly waived, no person has the right to require the Company or any of its subsidiaries to
register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or, to the knowledge of the Company, the sale of the Shares to be sold by the Selling Stockholder hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) <I>No Stabilization.</I> Neither the Company nor any of its subsidiaries or, to the Company&#146;s knowledge, affiliates
has taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any unlawful stabilization or manipulation of the price of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) <I>Forward-Looking Statements.</I> No forward-looking statement (within the meaning of Section&nbsp;27A of the Securities
Act and Section&nbsp;21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed
other than in good faith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) <I>Statistical and Market Data.</I> Nothing has come to the attention of the Company that
has caused the Company to believe that the statistical and market-related data included or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on or derived from sources
that are reliable and accurate in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) <I>Shelf Eligibility.</I> As of the date of this Agreement,
the Company is eligible to use Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Act and it meets the transaction requirements in accordance with General Instructions I.B.1 and I.D. of Form <FONT STYLE="white-space:nowrap">S-3.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) <I>Sarbanes-Oxley Act</I>. There is and has been no failure on the part of the Company or any of the Company&#146;s
directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith (the &#147;Sarbanes-Oxley Act&#148;),
including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss) <I>Status under the
Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule
164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company was not and is not an &#147;ineligible issuer&#148;, and was and is a well-known seasoned issuer, in each case as defined in Rule 405 under the Securities Act.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt) <I>Compliance with Laws Regarding Unauthorized Practice of Law.
</I>Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and except as would not reasonably be expected to have a Material Adverse Effect, the Company and each of its subsidiaries have complied, and
are presently in compliance with all applicable laws, rules and regulations regarding corporate practice of law and the unauthorized practice of law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Representations and Warranties of the Selling Stockholder</U>. The Selling Stockholder represents and warrants to each Underwriter and
the Company that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Consents; Authority</I>. All consents, approvals, authorizations and orders necessary
for the execution and delivery by the Selling Stockholder of this Agreement and for the sale and delivery of the Shares to be sold by the Selling Stockholder hereunder have been obtained, except where the failure to obtain any such consent,
approval, authorization or order would not reasonably be expected to have a material adverse effect on the ability of the Selling Stockholder to consummate the transactions contemplated by this Agreement and except such as may be required by the
Securities Act, the Exchange Act, the Nasdaq Market, FINRA or the securities or Blue Sky laws of the various states or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions in connection with the offer and sale of the Shares; and the
Selling Stockholder has full right, power and authority to enter into this Agreement and to sell, assign, transfer and deliver the Shares to be sold by the Selling Stockholder hereunder; this Agreement has been duly authorized, executed and
delivered by the Selling Stockholder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>No Conflicts</I>. The execution, delivery and performance by the Selling
Stockholder of this Agreement, the sale of the Shares to be sold by the Selling Stockholder and the consummation by the Selling Stockholder of the transactions contemplated herein will not (i)&nbsp;conflict with or result in a breach or violation of
any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Selling
Stockholder pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Selling Stockholder is a party or by which the Selling Stockholder is bound or to which any of the property, right or asset
of the Selling Stockholder is subject, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents of the Selling Stockholder or (iii)&nbsp;result in the
violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory agency having jurisdiction over the Selling Stockholder, except in the case of clauses (i)&nbsp;and (iii) above, for
any conflicts, breaches, violations, defaults, liens, charges or encumbrances which would not reasonably be expected to have a material adverse effect on the ability of the Selling Stockholder to consummate the transactions contemplated by this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Title to Shares. </I>The Selling Stockholder has, and immediately prior to the Closing Date and the
Additional Closing Date, as the case may be, the Selling Stockholder will have, good and valid title to, or a valid &#147;security entitlement&#148; within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-501</FONT> of the New York
Uniform Commercial Code in respect of, the Shares to be sold at the Closing Date or the Additional Closing Date, as the case may be, by the Selling Stockholder hereunder, free and clear of all liens, encumbrances, equities or adverse claims; and,
upon delivery of such Shares and payment therefor pursuant hereto, good and valid title to such Shares, free and clear of all liens, encumbrances, equities or adverse claims, will pass to the several Underwriters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>No Stabilization. </I>The Selling Stockholder has not taken and will not take, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any unlawful stabilization or manipulation of the price of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Accurate Disclosure</I>. To the extent, but only to the extent, that any statements or omissions made in the
Registration Statement, the Pricing Disclosure Package, the Prospectus or any amendment or supplement thereto are made in reliance upon and in conformity with any information relating to the Selling Stockholder furnished to the Company in writing by
the Selling Stockholder (the &#147;Selling Stockholder Information&#148;), such Registration Statement, Pricing Disclosure Package, Prospectus </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
and any further amendments or supplements thereto do not and will not contain any untrue statement of a material fact or omit to state any material fact (in the case of the Registration
Statement, required to be stated therein) or necessary to make the statements therein (in the case of the Pricing Disclosure Package or the Prospectus, in the light of the circumstances under which they were made) not misleading; it being understood
and agreed that the &#147;Selling Stockholder Information&#148; for the Selling Stockholder consists solely of the Selling Stockholder&#146;s legal name, the number of shares of Common Stock beneficially owned by the Selling Stockholder, before and
after the offering, and the address and other information with respect to the Selling Stockholder (excluding percentages) which appear in the table (and corresponding footnote) under the caption &#147;Selling Stockholder&#148; in the Pricing
Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Organization and Good Standing.</I> The Selling Stockholder has been duly
organized and is validly existing and in good standing under the laws of its respective jurisdictions of organization, except, in each case, as would not reasonably be expected to have a material adverse effect on the ability of the Selling
Stockholder to consummate the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>ERISA</I>. The Selling Stockholder is
not (i)&nbsp;an employee benefit plan subject to Title I of ERISA, (ii)&nbsp;a plan or account subject to Section&nbsp;4975 of the Code or (iii)&nbsp;an entity deemed to hold &#147;plan assets&#148; of any such plan or account under
Section&nbsp;3(42) of ERISA, 29 C.F.R. <FONT STYLE="white-space:nowrap">2510.3-101,</FONT> or otherwise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Further Agreements of the
Company</U>. The Company covenants and agrees with each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings.</I> The Company will
file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act, and will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the
Securities Act; the Company will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent
to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the
extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement (or such later time as may be agreed by the Company and the Representative)
in such quantities as the Representative may reasonably request. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule
(without giving effect to the proviso therein) and in any event prior to the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of Copies.</I>
The Company will deliver, if requested, without charge to each Underwriter (i)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (ii)&nbsp;during the Prospectus Delivery Period
(as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and each Issuer Free Writing Prospectus) as the Representative may reasonably request. As used herein, the term &#147;Prospectus Delivery
Period&#148; means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered
but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
<I>Amendments or Supplements, Issuer Free Writing Prospectuses.</I> Before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration
Statement, the Pricing Disclosure Package or the Prospectus (excluding any amendment or supplement through incorporation by reference of any report filed under the Exchange Act), the Company will furnish to the Representative and counsel for the
Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
or file any such proposed amendment or supplement to which the Representative reasonably object in a timely manner. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the Representative.</I> The Company will advise the Representative promptly, and confirm such advice in
writing (which may be by electronic mail), (i) when the Registration Statement has become effective; (ii)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (iii)&nbsp;when any supplement to the Pricing
Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or any amendment to the Prospectus has been filed
or distributed; (iv)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or
any other request by the Commission for any additional information including, but not limited to, any request for information concerning any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication; (v)&nbsp;of the issuance by the Commission or any other governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus,
any of the Pricing Disclosure Package, the Prospectus or any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or the initiation or, to the Company&#146;s knowledge, threatening
of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (vi)&nbsp;of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure
Package, any Issuer Free Writing Prospectus or any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication as then amended or supplemented would include any untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, any such Issuer Free Writing Prospectus or any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication is delivered to a purchaser, not misleading; (vii)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use
of the Registration Statement or any post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Securities Act; and (viii)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the qualification of the
Shares for offer and sale in any jurisdiction or the initiation or, to the Company&#146;s knowledge, the threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order
suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or any Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or suspending any such qualification of the Shares and, if any such order is issued, will use reasonable best efforts to obtain as soon as possible the withdrawal thereof.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Ongoing Compliance.</I> (1)&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event or development shall
occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the
light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly notify the Underwriters thereof and
forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representative may designate such amendments or supplements (or any document to be filed with the
Commission and incorporated by reference therein) to the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein)
will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law and (2)&nbsp;if at any time prior to the Closing Date or any Additional Closing Date,
as the case may be, (i)&nbsp;any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the
Pricing Disclosure Package to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the
Underwriters and to such dealers as the Representative may designate such amendments or supplements to the Pricing Disclosure Package (or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will
not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Blue Sky Compliance.</I> The Company will use its reasonable best efforts, with the Underwriters&#146; cooperation, if
necessary, to qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representative shall reasonably request and will use its reasonable best efforts, with the Underwriters&#146; cooperation, if
necessary, to continue such qualifications in effect so long as required for distribution of the Shares; <U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities
in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not
otherwise so subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Earnings Statement. </I>The Company will make generally available to its stockholders and the
Representative as soon as practicable an earnings statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with
the first fiscal quarter of the Company occurring after the &#147;effective date&#148; (as defined in Rule 158) of the Registration Statement, provided that the Company will be deemed to have furnished such statement to its stockholders and the
Representative to the extent it is filed on the Commission&#146;s Electronic Data, Gathering, Analysis and Retrieval system (&#147;EDGAR&#148;) or any successor system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Clear Market.</I> For a period ending on the later of (A)&nbsp;the close of business on the 60th day after the date set
forth on the cover of the Prospectus and (B)&nbsp;the opening of trading on the date that is the second full trading day immediately following the Company&#146;s public release of earnings for its third quarter ending September&nbsp;30, 2023 (the
&#147;Restricted Period&#148;), the Company will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise
transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for
Stock, or publicly disclose the intention to undertake any of the foregoing, or (ii)&nbsp;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other
securities, whether any such transaction described in clause (i)&nbsp;or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written consent of J.P. Morgan Securities LLC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions described above do not apply to (i)&nbsp;the issuance of shares of Stock or securities convertible into or
exercisable for shares of Stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net or cashless exercise) or the settlement of RSUs (including net or cashless
settlement), in each case outstanding on the date of this Agreement and described in the Prospectus; (ii)&nbsp;grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of Stock or securities
convertible into or exercisable or exchangeable for shares of Stock (whether upon the exercise of stock options or otherwise) to the Company&#146;s employees, officers, directors, advisors, or consultants pursuant to the terms of an equity
compensation plan in effect as of the Closing Date and described in the Prospectus, provided that such recipients who are executive officers and directors enter into or are subject to a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement with
the Underwriters; (iii)&nbsp;the issuance by the Company of shares of Stock or securities convertible into, exchangeable for or that represent the right to receive shares of Stock in connection with (1)&nbsp;the acquisition by the Company or any of
its subsidiaries of the securities, business, technology, property or other assets of another person or entity or pursuant to an employee benefit plan assumed by the Company in connection with such acquisition, and the issuance of any such
securities pursuant to any such agreement, or (2)&nbsp;the Company&#146;s joint ventures, commercial relationships and other strategic transactions; (iv)&nbsp;the establishment of a trading plan pursuant to Rule
<FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act, provided that such plan (1)&nbsp;does not provide for the transfer of shares of Stock during the Restricted Period and (2)&nbsp;any public announcement or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
filing under the Exchange Act made by any person regarding the establishment of such plan during the Restricted Period shall include a statement that the Company is not permitted to transfer,
sell or otherwise dispose of securities under such plan during the Restricted Period; (v)&nbsp;any transaction effectuated pursuant to a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> that has been entered into by the
Company prior to the date of this Agreement, provided that (1)&nbsp;the existence of such trading plan under Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> was communicated to the Underwriters prior to the execution of this Agreement,
(2)&nbsp;such trading plan under Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> will not be amended or otherwise modified to increase shares scheduled for sale thereunder during the Restricted Period and (3)&nbsp;any public announcement or
filings under the Exchange Act made in connection with this clause (v)&nbsp;shall include an explanatory footnote stating the nature of the transfer; or (vi)&nbsp;the filing by the Company of any registration statements on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-8&nbsp;or</FONT> a successor form thereto relating to securities granted or to be granted pursuant to the Company Stock Plans or any assumed employee benefit contemplated by clause (iii); provided, that the
aggregate number of shares of Stock that the Company may sell or issue or agree to sell or issue pursuant to clause (iii)&nbsp;shall not exceed 10% of the total number of shares of Stock outstanding immediately following the offering of the Shares
contemplated by this Agreement plus the shares reserved for issuance under the Company Stock Plans and provided, further, that in the case of clause (iii)&nbsp;each recipient of such securities during the&nbsp;Restricted Period shall enter into a <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement with the Underwriters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>No Stabilization.</I> Neither the
Company nor its subsidiaries or affiliates will take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any unlawful stabilization or manipulation of the price of the Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Exchange Listing.</I> The Company will use its commercially reasonable efforts to maintain the listing of the Shares on
the Nasdaq Market. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Reports.</I> For a period of two years from the date of this Agreement, so long as the Company
is subject to the reporting requirements of either Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act, the Company will furnish to the Representative, as soon as they are available, copies of all reports or other communications (financial or
other) furnished to holders of the Shares, and copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system; <U>provided</U> the Company will be deemed to
have furnished such reports and financial statements to the Representative to the extent they are filed on EDGAR or any successor system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Record Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each
Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Further
Agreements of the Selling Stockholder</U>. The Selling Stockholder covenants and agrees with the Company and each Underwriter that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<I> <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</I>. The Selling Stockholder has duly executed a <FONT
STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement, in substantially the form of Exhibit B hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<I> No
Stabilization. </I>The Selling Stockholder will not take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any unlawful stabilization or manipulation of the price of the Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<I> Tax Form. </I>The Selling Stockholder will deliver to the Representative prior to or at the Closing Date a properly
completed and executed United States Treasury Department Form <FONT STYLE="white-space:nowrap">W-9</FONT> or applicable Form <FONT STYLE="white-space:nowrap">W-8</FONT> (or other applicable form or statement specified by the Treasury Department
regulations in lieu thereof) in order to facilitate the Underwriters&#146; documentation of their compliance with the reporting and withholding provisions of Section&nbsp;3406 of the Internal Revenue Code of 1986, as amended, with respect to the
transactions herein contemplated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Certification Regarding Beneficial Owners</I>. The Selling
Stockholder will deliver to each Underwriter (or its agent), prior to the date of execution of this Agreement, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of identifying
documentation, and the Selling Stockholder undertakes to provide such additional supporting documentation as each Underwriter may reasonably request in connection with the verification of the foregoing Certification. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Use of Proceeds</I>. The Selling Stockholder will not directly or indirectly use the proceeds of the offering of the
Shares hereunder, or lend, contribute or otherwise make available such proceeds to a subsidiary, joint venture partner or other person or entity (i)&nbsp;to fund or facilitate any activities of or business with any person that, at the time of such
funding or facilitation, is the subject of target of Sanctions, in violation of Sanctions, (ii)&nbsp;to fund or facilitate any activities of or business in any Sanctioned Country in violation of Sanctions or (iii)&nbsp;in any other manner that will
result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions; provided that the foregoing shall not apply with respect to the distribution of the
proceeds of the offering to any of the Selling Stockholder&#146;s direct or indirect limited partners, members or other equity holders once such proceeds are no longer under the control of the Selling Stockholder if prior to such distribution the
Selling Stockholder has no knowledge that such proceeds will be used for any of the foregoing purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Certain Agreements of the
Underwriters</U>. Each Underwriter hereby severally represents and agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and will not use, authorize
use of, refer to or participate in the planning for use of, any &#147;free writing prospectus&#148;, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and
not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i)&nbsp;a free writing prospectus that contains no &#147;issuer information&#148; (as defined in Rule 433(h)(2) under the
Securities Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Annex A or prepared
pursuant to Section&nbsp;3(c) or Section&nbsp;4(c) above (including any electronic road show approved in advance by the Company), or (iii)&nbsp;any free writing prospectus prepared by such Underwriter and approved by the Company in advance in
writing (each such free writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;Underwriter Free Writing Prospectus&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains
the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <U>provided</U> that Underwriters may use a term sheet substantially in the form of Annex C hereto without the
consent of the Company; <U>provided further</U> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or substantially concurrently with, the first use of such term
sheet. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with respect to the
offering (and will promptly notify the Company and the Selling Stockholder if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Conditions of Underwriters&#146; Obligations.</U> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing
Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company and the Selling Stockholder of their respective covenants and other obligations hereunder and to the
following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order.</I> No order suspending the effectiveness
of the Registration Statement shall be in effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or, to the Company&#146;s knowledge, threatened by the Commission; the Prospectus
and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;5(a) hereof; and all requests by the Commission for additional information shall have been complied with to the
reasonable satisfaction of the Representative. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Representations and Warranties.</I> The respective representations
and warranties of the Company and the Selling Stockholder contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its
officers and of the Selling Stockholder and its authorized signatories made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Downgrade</I>. Subsequent to the earlier of (A)&nbsp;the Applicable Time and (B)&nbsp;the execution and delivery of
this Agreement, (i)&nbsp;no downgrading shall have occurred in the rating accorded any debt securities, convertible securities or preferred stock issued, or guaranteed by, the Company or any of its subsidiaries by any &#147;nationally recognized
statistical rating organization&#148;, as such term is defined under Section&nbsp;3(a)(62) under the Exchange Act and (ii)&nbsp;no such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook
with respect to, its rating of any such debt securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>No Material Adverse Change.</I> No event or condition of a type described in Section&nbsp;3(h) hereof shall have
occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the
judgment of the Representative makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by
this Agreement, the Pricing Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Officer&#146;s Certificate.</I> The
Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, (x)&nbsp;a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive
officer of the Company who is satisfactory to the Representative, on behalf of the Company and not in their individual capacities, (i)&nbsp;confirming that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure
Package and the Prospectus and, to the knowledge of such officers, the representations of the Company set forth in Sections 3(b) and 3(d) hereof are true and correct, (ii)&nbsp;confirming that the other representations and warranties of the Company
in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case
may be, and (iii)&nbsp;to the effect set forth in paragraphs (a)&nbsp;and (c) above and (y)&nbsp;a certificate of the Selling Stockholder, in form and substance reasonably satisfactory to the Representative, (i)&nbsp;confirming that the
representations of the Selling Stockholder set forth in Section&nbsp;4(e) hereof is true and correct and (ii)&nbsp;confirming that the other representations and warranties of the Selling Stockholder in this Agreement are true and correct and that
the Selling Stockholder has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Comfort Letters.</I> On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case
may be, PricewaterhouseCoopers LLP shall have furnished to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Representative, in form and substance reasonably satisfactory
to the Representative, containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained or
incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
case may be, shall use a <FONT STYLE="white-space:nowrap">&#147;cut-off&#148;</FONT> date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case
may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the Company.</I> Cooley
LLP, counsel for the Company, shall have furnished to the Representative, at the request of the Company, its written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> statement, dated the Closing Date or the Additional Closing Date, as the
case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)
O<I>pinion of Counsel for the Selling Stockholder</I>. Fried, Frank, Harris, Shriver&nbsp;&amp; Jacobson LLP, counsel for the Selling Stockholder, shall have furnished to the Representative, at the request of the Selling Stockholder, their written
opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the Underwriters.</I> The
Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, a written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> statement, addressed to the Underwriters, of Latham&nbsp;&amp;
Watkins LLP, counsel for the Underwriters, with respect to such matters as the Representative may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such
matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No Legal Impediment to Sale.</I> No action shall have been taken and no statute, rule, regulation or order
shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the sale of the Shares; and no injunction
or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the sale of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Good Standing</I>. The Representative shall have received on and as of the Closing Date or the Additional Closing Date,
as the case may be, satisfactory evidence of the good standing (or its jurisdictional equivalent) of the Company and its significant subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions
as the Representative may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) [<I>Reserved.</I>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</I>. The
<FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreements, each substantially in the form of Exhibit B hereto, between the Representative and the Selling Stockholder and certain officers and directors of the Company relating to sales
and certain other dispositions of shares of Stock or certain other securities, delivered to the Representative on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Additional Documents.</I> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the
Company and the Selling Stockholder shall have furnished to the Representative such further certificates and documents as the Representative may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Indemnification
and Contribution</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of the Underwriters by the Company.</I> The Company agrees to indemnify and hold harmless
each Underwriter, its affiliates, directors and officers and each person, if any, who controls such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including,
without limitation, reasonable and documented legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are based
upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in
order to make the statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free
Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication, any road show as defined in Rule 433(h) under the Securities Act (a &#147;road show&#148;) or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or
alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities
arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with the Underwriter Information or the Selling Stockholder Information, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of the Underwriters by the Selling Stockholder</I>. The Selling Stockholder agrees to indemnify and hold harmless each
Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set
forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with the Selling Stockholder Information relating to the Selling Stockholder furnished to the Company in writing by the Selling Stockholder; provided, however, that the liability of the Selling Stockholder pursuant to this paragraph
(b)&nbsp;shall not exceed the net proceeds (before deducting expenses) received by the Selling Stockholder from the sale of the Shares sold by the Selling Stockholder hereunder (the &#147;Selling Stockholder Net Proceeds&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Indemnification of the Company and the Selling Stockholder.</I> Each Underwriter agrees, severally and not jointly, to indemnify and
hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act and the
Selling Stockholder to the same extent as the indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in the Registration
Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended) (the &#147;Underwriter Information&#148;), it being understood and agreed upon that the only Underwriter
Information consists of the following information in the Prospectus: the concession and reallowance figures appearing in the third paragraph under the caption &#147;Underwriting&#148; and the information contained in the 21st and 22nd paragraph
under the caption &#147;Underwriting&#148; relating to price stabilization, shorting and penalty bids. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice and Procedures.</I>
If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this
Section&nbsp;9, such person (the &#147;Indemnified Person&#148;) shall promptly notify the person against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the failure to notify the
Indemnifying Person shall not relieve it from any liability that it may have under the preceding paragraphs of this Section&nbsp;9 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses)
by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this
Section&nbsp;9. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified
Person (who shall not, without the consent of the Indemnified </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section&nbsp;9 that the Indemnifying Person may
designate in such proceeding and shall pay the reasonable and documented fees and expenses in such proceeding and shall pay the reasonable and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such
proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall
have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded that
there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying
Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in
connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable and documented fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all
such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the
Representative, any such separate firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company and any such separate firm for the Selling
Stockholder shall be designated in writing by the Selling Stockholder. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, the Indemnifying Person
agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse
the Indemnified Person for reasonable and documented fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such
settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such
settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and
indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from
all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Contribution.</I> If the indemnification provided for in paragraphs (a), (b) or (c)&nbsp;above is unavailable to an Indemnified Person
or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or
payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company and the Selling Stockholder, on the one hand, and
the Underwriters, on the other, from the offering of the Shares or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to
in clause (i)&nbsp;but also the relative fault of the Company and the Selling Stockholder, on the one hand, and the Underwriters, on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Selling Stockholder, on the one hand, and the Underwriters, on the other, shall be deemed to be in the same respective
proportions as the net proceeds (before deducting expenses) received by the Selling Stockholder from the sale of the Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as
set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the Company and the Selling Stockholder, on the one hand, and the Underwriters, on the other, shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company and the Selling Stockholder or by the
Underwriters, and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Limitation on Liability.</I> The Company, the Selling Stockholder and the
Underwriters agree that it would not be just and equitable if contribution pursuant to paragraph (e)&nbsp;above were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any
other method of allocation that does not take account of the equitable considerations referred to in paragraph (e)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to
in paragraph (e)&nbsp;above shall be deemed to include, subject to the limitations set forth above, any reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal or other expenses
incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (e)&nbsp;and (f), (i) in no event shall an Underwriter be required to contribute any amount in excess of the amount by
which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission and (ii)&nbsp;the Selling Stockholder&#146;s obligation to contribute any amount pursuant to paragraphs (e)&nbsp;and (f) is limited in the manner and to the extent set forth in paragraph
(b)&nbsp;of this Section&nbsp;9 and the Selling Stockholder shall not be required to contribute any amount in excess of the Selling Stockholder Net Proceeds. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)
of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute pursuant to paragraphs (e)&nbsp;and (f) are several in proportion to
their respective purchase obligations hereunder and not joint. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies.</I>
The remedies provided for in this Section&nbsp;9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. For the avoidance of doubt, the provisions of this
Section&nbsp;9 shall not affect any agreement among the Company and the Selling Stockholder with respect to indemnification or contribution. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Effectiveness of Agreement</U>. This Agreement shall become effective as of the date first written above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Termination</U>. This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Company and the
Selling Stockholder, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date (i)&nbsp;trading generally shall have been suspended or
materially limited on or by any of the New York Stock Exchange or The Nasdaq Stock Market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv)&nbsp;there shall have occurred any outbreak
or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to
proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Defaulting Underwriter</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the
Shares that it has agreed to purchase hereunder on such date, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company and
the Selling Stockholder on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Shares,
then the Company and the Selling Stockholder shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Shares on
such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company and the Selling Stockholder may postpone the
Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company, counsel for the Selling Stockholder or counsel for the Underwriters may
be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus that effects any such changes. As used in this Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Agreement unless the context otherwise requires, any
person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;12, purchases Shares that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, the Company and the Selling Stockholder as provided in paragraph (a)&nbsp;above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing
Date, as the case may be, does not exceed <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate number of Shares to be purchased on such date, then the Company and the Selling Stockholder shall have the right to require each <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&#146;s pro rata share (based on the number of Shares that such
Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, the Company and the Selling Stockholder as provided in paragraph (a)&nbsp;above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing
Date, as the case may be, exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate amount of Shares to be purchased on such date, or if the Company and the Selling Stockholder shall not exercise the right described in paragraph
(b)&nbsp;above, then this Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;12 shall be without liability on the part of the Company and the Selling Stockholder, except that the Company and the
Selling Stockholder will continue to be liable for the payment of expenses as set forth in Section&nbsp;13(a) hereof and except that the provisions of Section&nbsp;9 hereof shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company, the Selling Stockholder or any
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Payment of
Expenses</U><I>.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated,
(A)&nbsp;the Company will pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and
delivery of the Shares and, subject to clause (B)&nbsp;below, any stock transfer taxes payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, any
Preliminary Prospectus, any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Watters</FONT></FONT> Communication, any Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all
exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the fees and expenses of the Company&#146;s counsel and independent accountants; (iv)&nbsp;the reasonable fees and expenses incurred in connection with the
registration or qualification and determination of eligibility for investment of the Shares under the laws of such jurisdictions as the Representative may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including
the related fees and expenses of counsel for the Underwriters);&nbsp;(v) the cost of preparing stock certificates; (vi)&nbsp;the costs and charges of any transfer agent and any registrar; (vii)&nbsp;all expenses and application fees incurred in
connection with any filing with, and clearance of the offering by, FINRA, provided, however, that the amounts payable by the Company for the fees and disbursements of counsel to the Underwriters pursuant to subsections (iv)&nbsp;and (vii) shall not
exceed $25,000 in the aggregate; (viii)&nbsp;all expenses incurred by the Company in connection with any &#147;road show&#148; presentation to potential investors (<U>provided, however </U>that the Company shall only pay 50% of the cost of any
aircraft or other transportation chartered in connection therewith (the remaining 50% of the cost of such aircraft or other transportation paid by the Underwriters); and (ix)&nbsp;all expenses and application fees related to the listing of the
Shares on the Nasdaq Market; and (B)&nbsp;subject to the Company&#146;s investor rights agreement pursuant to which, the Company will pay the expenses of one counsel to the Selling Stockholder and all other registration expenses of the Selling
Stockholder provided therein, the Selling Stockholder will pay or cause to be paid all other costs and expenses incident to the performance of the Selling Stockholder&#146;s obligations hereunder which are not otherwise specifically provided for in
this Section, in each case to the extent not paid by the Company, including all transfer taxes incident </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the sale and delivery of the Shares to be sold by the Selling Stockholder to the Underwriters hereunder. It is understood, however, that except to the extent otherwise provided in this
Section&nbsp;13 or Section&nbsp;9, the Underwriters will pay all of their costs and expenses, including fees and expenses of their counsel, stock transfer taxes payable on resale of any of the Shares held by them, and any advertising expenses
connected with any offers they may make and lodging expenses incurred by them in connection with any &#147;road show&#148;, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If&nbsp;this Agreement is terminated by the Underwriters pursuant to clause (ii)&nbsp;of Section&nbsp;11 or by reason of any failure,
refusal or inability on the part of the Company to perform any undertaking or satisfy any condition of this Agreement or to comply with any of the terms hereof on its part to be performed or satisfied, the Company agrees to reimburse the
Underwriters for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">all&nbsp;out-of-pocket&nbsp;costs</FONT></FONT> and expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in connection
with this Agreement and the offering contemplated hereby. If the Selling Stockholder shall fail at the Closing Date to tender the Shares for delivery to the Underwriters (other than by reason of a default by an Underwriter or the Company) or this
Agreement is terminated by the Underwriters by reason of any failure, refusal or inability on the part of the Selling Stockholder to perform any undertaking or satisfy any condition of this Agreement or to comply with any of the terms hereof on its
part to be performed or satisfied, the Selling Stockholder agrees to reimburse the Underwriters for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">all&nbsp;out-of-pocket&nbsp;costs</FONT></FONT> and expenses (including the fees
and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred to in Section&nbsp;9 hereof. Nothing in this Agreement is intended or shall be construed to
give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such
purchase. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and agreements of the
Company, the Selling Stockholder and the Underwriters contained in this Agreement or made by or on behalf of the Company, the Selling Stockholder or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall
survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company, the Selling Stockholder or the Underwriters or
the directors, officers, controlling persons or affiliates referred to in Section&nbsp;9 hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Certain Defined Terms</U>. For
purposes of this Agreement, (a)&nbsp;except where otherwise expressly provided, the term &#147;affiliate&#148; has the meaning set forth in Rule 405 under the Securities Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day
on which banks are permitted or required to be closed in New York City; and (c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in Rule 405 under the Securities Act; and (d)&nbsp;the term &#147;significant subsidiary&#148; has the
meaning set forth in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Compliance with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT
STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company and the Selling Stockholder
which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Miscellaneous</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<I>Notices.</I> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be
given to the Representative, J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: (212) <FONT STYLE="white-space:nowrap">622-8358).</FONT> Notices to the Company shall be given to it at LegalZoom.com, Inc., 101 North Brand
Boulevard, 11th Floor, Glendale, California 91203; Attention: General Counsel <FONT STYLE="white-space:nowrap">(e-mail:</FONT> [***]). Notices to the Selling Stockholder shall be given to it at c/o Permira Advisers LLC, 3000
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sand Hill Road, Building 1, Suite 170, Menlo Park, California 94025; Attention: Molly Breen Dirscherl (email: [***]). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Governing Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by
and construed in accordance with the laws of the State of New York. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Waiver of Jury Trial. </I>Each of the parties hereto hereby
waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Submission to
Jurisdiction</I>. Each of the Company and the Selling Stockholder hereby submit to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of
or relating to this Agreement or the transactions contemplated hereby. Each of the Company and the Selling Stockholder waive any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each
of the Company and the Selling Stockholder agree that a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and the
Selling Stockholder, as applicable, and may be enforced in any court to the jurisdiction of which Company and the Selling Stockholder, as applicable, is subject by a suit upon such judgment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Counterparts.</I> This Agreement may be signed in two or more counterparts, each of which shall be an original, with the same effect as
if the signatures thereto and hereto were upon the same instrument. Counterparts may be delivered via facsimile, electronic mail (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective as delivery of a manually executed counterpart of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Recognition of the U.S. Special Resolution Regimes</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any
such interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any
Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted
to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;18(f): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12
U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;Covered Entity&#148; means any of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b);
or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;Default Right&#148; has the meaning assigned to that term in, and shall be interpreted
in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;U.S. Special Resolution Regime&#148; means each of
(i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Amendments or Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure
therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Headings.</I> The
headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[signature page follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>LEGALZOOM.COM, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Dan Wernikoff</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Dan Wernikoff</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>LUCASZOOM, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas Lafrance</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Thomas Lafrance</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted: As of the date first written above</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>J.P. MORGAN SECURITIES LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For itself and on behalf of the several Underwriters listed in Schedule 1 hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ilana Foni</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE 1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Number&nbsp;of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Underwritten</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,568,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,368,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,368,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">933,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">933,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jefferies LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">933,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">933,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citizens JMP Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">622,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond James&nbsp;&amp; Associates, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">622,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Blair&nbsp;&amp; Company, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">622,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AmeriVet Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Penserra Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telsey Advisory Group LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE 2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Selling Stockholder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number of<BR>Underwritten&nbsp;Shares:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number of<BR>Option&nbsp;Shares:</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LucasZoom, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX A </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a. <B>Pricing Disclosure Package</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Free
Writing Prospectuses: None. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b. <B>Pricing Information Provided Orally by Underwriters</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Public offering price per share: $10.00 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Number of Underwritten Shares to be sold by the Selling Stockholder: 14,000,000&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Number of Option Shares to be sold by the Selling Stockholder: 2,100,000 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriting Discounts and Commissions: $0.45 per Share </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX B </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LegalZoom.com, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Pricing
Term Sheet </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;Testing the Waters&#148; Authorization </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September [&nbsp;<FONT STYLE="FONT-SIZE:70%">&#9899;</FONT>&nbsp;], 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RE: &#147;Testing the Waters&#148;
Authorization </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In reliance on Rule
163B under the Securities Act of 1933, as amended (the &#147;Act&#148;), LegalZoom.com, Inc. (the &#147;Company&#148;) hereby authorizes J.P. Morgan Securities LLC (&#147;J.P. Morgan&#148;) and its affiliates and their respective employees to engage
on behalf of the Company in oral and written communications with potential investors that are reasonably believed to be &#147;qualified institutional buyers&#148;, as defined in Rule 144A under the Act, or institutions that are &#147;accredited
investors&#148;, within the meaning of Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Act, to determine whether such investors might have an interest in the contemplated public offering of the Company&#146;s
securities <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(&#147;Testing-the-Waters</FONT></FONT> Communications&#148;). A &#147;Written <FONT STYLE="white-space:nowrap">Testing-the</FONT> Waters Communication&#148; means any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written communication within the meaning of Rule 405 under the Act. J.P. Morgan agrees that it shall not distribute any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that has not been approved by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
at any time following the distribution of any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication through the closing or abandonment of the contemplated public offering there
occurs an event or development as a result of which such Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication included or would include an untrue statement of a material fact or
omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify J.P. Morgan and will promptly
amend or supplement, at its own expense, such Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication to eliminate or correct such untrue statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nothing in this authorization is intended to limit or otherwise affect the ability of J.P. Morgan and its affiliates and their respective employees to engage
in communications in which they could otherwise lawfully engage in the absence of this authorization, including, without limitation, any written communication containing only one or more of the statements specified under Rule 134(a) under the Act.
This authorization shall remain in effect until the Company has provided to J.P. Morgan a written notice revoking this authorization. All notices as described herein shall be sent by email to the attention of Alice Takhtajan at [***] and Ilana Foni
at [***], with copies to Rick Kline at [***] and Adam Gelardi at [***]. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LegalZoom.com, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to &#147;Testing the Waters&#148; Authorization</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Acknowledged and agreed as of the date above written</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to &#147;Testing the Waters&#148; Authorization</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representative of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the several Underwriters listed in </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule 1 to the
Underwriting </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agreement referred to below </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan
Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10179 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Re: LegalZoom.com, Inc. &#151; Public Offering </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned
understands that J.P. Morgan Securities LLC, as Representative of the several Underwriters (the &#147;Representative&#148;), proposes to enter into an underwriting agreement (the &#147;Underwriting Agreement&#148;) with LegalZoom.com, Inc., a
Delaware corporation (the &#147;Company&#148;), and the Selling Stockholder listed on Schedule 2 to the Underwriting Agreement (the &#147;<U>Selling Stockholder</U>&#148;), providing for the public offering (the &#147;Public Offering&#148;) by the
several Underwriters named in Schedule 1 to the Underwriting Agreement (the &#147;Underwriters&#148;), of common stock, $0.001 per share par value, of the Company (the &#147;Common Stock&#148;) owned by the Selling Stockholder (the
&#147;Securities&#148;). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the Underwriters&#146; agreement to purchase and make the Public Offering of the Securities, and for other good and
valuable consideration, the receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of J.P. Morgan Securities LLC on behalf of the several Underwriters, the undersigned will not, and will not
cause any direct or indirect controlled affiliate to, during the period beginning on the date of this letter agreement (this &#147;Letter Agreement&#148;) and ending on the later of (x)&nbsp;the close of business on the 60th day after the date set
forth on the cover of the final prospectus supplement relating to the Public Offering (the &#147;Prospectus&#148;) and (y)&nbsp;the opening of trading on the date that is the second full trading day immediately following the Company&#146;s public
release of earnings for its third quarter ending September&nbsp;30, 2023 (the &#147;Restricted Period&#148;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (including without limitation,
Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock
option or warrant) (the &#147;Other Securities&#148; and together with the Common Stock, the <FONT STYLE="white-space:nowrap">&#147;Lock-up</FONT> Securities&#148;), or publicly disclose the intention to make any offer, sale, pledge or disposition,
(2)&nbsp;enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause
(1)&nbsp;or (2) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, or (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security
convertible into or exercisable or exchangeable for Common Stock, in each case other than the Securities to be sold by the undersigned pursuant to the Underwriting Agreement and the shares </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Common Stock, if any, to be sold by the undersigned pursuant to the Stock Repurchase (as defined in the Prospectus). The undersigned acknowledges and agrees that the foregoing precludes the
undersigned from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other
derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned or any other person) of any
economic consequences of ownership, in whole or in part, directly or indirectly, of any <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled
by delivery of Common Stock or other securities, in cash or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the undersigned may transfer or
otherwise dispose of the undersigned&#146;s <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as a bona fide gift or gifts, as charitable contributions or for bona fide estate planning purposes;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">upon death or by will or intestacy, including to any beneficiary of, estate of a beneficiary or a member of the
immediate family of the undersigned pursuant to, a trust, will, other testamentary document or applicable laws of descent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any corporation, partnership, limited liability company or trust for the direct or indirect benefit of the
undersigned or the immediate family of the undersigned, or if the undersigned is a trust or other estate planning vehicle, to a trustor or beneficiary of the trust or other estate planning vehicle or to the estate of a beneficiary of such trust or
other estate planning vehicle in a transaction not including a disposition for value; for purposes of this Letter Agreement, &#147;immediate family&#148; shall mean any relationship by blood, current or former marriage, domestic partnership or
adoption, not more remote than first cousin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under
clauses (1)&nbsp;through (3) above and (12)&nbsp;below, and in each such case, subject to the same conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pursuant to an order of a court or regulatory agency having jurisdiction over the undersigned or by operation
of law, such as pursuant to a final qualified domestic order, divorce settlement, divorce decree or separation agreement or other final court order; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the Company or to an affiliate of the Company (A)&nbsp;pursuant to agreements under which the Company has
the option to repurchase such shares or (B)&nbsp;upon death, disability or termination of employment or other service relationship with the Company, in each case, of such employee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a corporation, partnership, limited liability company, trust or other business entity,
(A)&nbsp;to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned, or to any investment
fund or other entity directly or indirectly controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a
partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B)&nbsp;as part of a distribution, transfer or disposition without consideration by the undersigned to its stockholders,
partners, members, managers, limited partners, subsidiaries, affiliates or other equity holders (or, in each case, its nominee or custodian); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the undersigned acquired in open market transactions after the completion of the Public Offering;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(A) to the Company for the purposes of exercising (including for the payment of tax withholdings or remittance
payments due as a result of such exercise) on a &#147;net exercise&#148; or &#147;cashless&#148; basis options, warrants or other rights to purchase shares of Common Stock and (B)&nbsp;in connection with the vesting or settlement of restricted stock
units, by way of any transfer to the Company for the payment of tax withholdings or remittance payments due as a result of the vesting or settlement of such restricted stock units, and/or if the undersigned is not an officer or director any transfer
of shares of Common Stock necessary to generate such amount of cash needed for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of restricted stock units; <U>provided</U> that in all such cases under
clause (A)&nbsp;or (B), any such options, warrants, rights or restricted stock units were issued pursuant to equity awards granted under a stock incentive plan or other equity award plan, which plan is described in the Prospectus; <U>provided</U>
further that any </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
shares of <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities received as a result of such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is
approved by the Board of Directors of the Company involving one transaction or a series of related transactions that results in a change of control of the Company in which the acquiring party becomes the beneficial owner (as defined in Rules <FONT
STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)) of more than 50% of total voting power of the outstanding voting stock of
the Company following such transaction; <U>provided</U> that all of the undersigned&#146;s <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities subject to this Letter Agreement that are not so transferred, sold, tendered or otherwise disposed
of remain subject to this Letter Agreement; <U>provided further</U>, that in the event that such tender offer, merger, consolidation or other similar transaction is not completed, the undersigned&#146;s
<FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities shall remain subject to the provisions of this Letter Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in connection with the sale or other transfer of Common Stock made pursuant to a trading plan designed to
comply with Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act (as such rule was in effect at the time any such trading plan was adopted) that has been entered into by the undersigned prior to the date of this Letter
Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any corporation, partnership, limited liability company or other entity of which the undersigned or the
immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar interests; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U> that: (i)&nbsp;in the case of any transfer or distribution pursuant to clauses (1), (2), (3), (4), (5), (7) and (12), each donee, transferee
or distributee shall execute and deliver to the Representative a <FONT STYLE="white-space:nowrap">lock-up</FONT> letter in the form of this Letter Agreement, except in the case of clause&nbsp;(5) where a court or regulatory agency of competent
jurisdiction requires such transfer or distribution to be made without such restriction; (ii)&nbsp;in the case of any transfer or distribution pursuant to clauses (3), (4) or (12), no filing by any party (donor, donee, transferor or transferee)
under the Exchange Act, or other public announcement reporting a reduction in beneficial ownership of shares of Common Stock shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a
Form 5 made after the expiration of the Restricted Period referred to above); (iii) in the case of any transfer or distribution pursuant to clause (8), no filing by any party (donor, donee, transferor or transferee) under the Exchange Act, or other
public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a Form&nbsp;5 made after the expiration of the Restricted Period referred to above); and (iv)&nbsp;in the
case of any transfer or other disposition pursuant to clauses (1), (5), (6), (7), (9) and (11), it shall be a condition to such transfer or disposition that any filing under Section&nbsp;16 of the Exchange Act, or other public filing, report or
announcement reporting a reduction in beneficial ownership of shares of Common Stock shall clearly indicate in the footnotes thereto the nature and conditions of such transfer or disposition described in clause (1), (5), (6), (7), (9) or (11), as
the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, notwithstanding the restrictions imposed by this Letter Agreement, the undersigned may exercise an option
or other equity awards to purchase shares of Common Stock, receive shares that vest under restricted stock units or exercise warrants, <U>provided</U> that the shares of Common Stock issued upon such exercise or vesting shall continue to be subject
to the restrictions on transfer set forth in this Letter Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is not a natural person, the undersigned
represents and warrants that no single natural person, entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d)(3) of the Exchange Act) beneficially owns, directly or indirectly, 50% or more of the common equity interests, or 50% or
more of the voting power, in the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Letter Agreement shall prevent the establishment by the undersigned of any
contract, instruction or plan (a &#147;Plan&#148;) meeting the requirements of Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of Common Stock, <U>provided</U> that (1)&nbsp;such Plan does not
provide for the sale of <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities during the Restricted Period and (2)&nbsp;no filing under the Exchange Act or other public announcement or disclosure shall be made during the Restricted Period in
connection with the establishment of such Plan unless such filing, other public announcement or disclosure includes a statement to the effect that no sale of the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities may be made under the Plan
during the Restricted Period, <U>provided</U> that this clause (2)&nbsp;shall not apply to any disclosures required to be made by the Company pursuant to the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby consents to receipt of this Letter Agreement in electronic form and understands and agrees that this Letter Agreement
may be signed electronically. In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by electronic transmission evidencing an intent to sign this Letter Agreement, such facsimile transmission,
electronic mail or other electronic transmission shall create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution and delivery of this Letter Agreement by facsimile
transmission, electronic mail or other electronic transmission is legal, valid and binding for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby
represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors,
assigns, heirs or personal representatives of the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the Underwriters have not
provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial,
regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Representative may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in
connection with the Public Offering, the Representative and the other Underwriters are not making a recommendation to you to participate in the Public Offering, enter into this Letter Agreement, or sell any Shares at the price determined in the
Public Offering, and nothing set forth in such disclosures is intended to suggest that the Representative or any Underwriter is making such a recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby waives any and all notice requirements and rights with respect to the registration of securities pursuant to any
agreement, understanding or anything otherwise setting forth the terms of any security of the Company held by the undersigned, including any registration rights agreement or investors&#146; rights agreement to which the undersigned and the Company
may be party; <U>provided, however</U>, that such waiver shall apply only to the proposed Public Offering, and any other action taken by the Company in connection with the proposed Public Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that, if (i)&nbsp;the Underwriting Agreement does not become effective by September&nbsp;15, 2023, (ii) either
J.P. Morgan Securities LLC, the Company or the Selling Stockholder informs the other parties, prior to the execution of the Underwriting Agreement, that such party has determined not to proceed with the Public Offering, (iii)&nbsp;the Registration
Statement is withdrawn or (iv)&nbsp;the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder, the undersigned
shall be released from all obligations under this Letter Agreement. The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and
construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[signature page
follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name of Securityholder <I>(Print exact name</I>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">If not signing in an individual capacity:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name of Authorized Signatory <I>(Print</I>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title of Authorized Signatory <I>(Print</I>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d485281dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>EXECUTION VERSION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>STOCK PURCHASE AGREEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>T<SMALL>HIS</SMALL> S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL> A<SMALL>GREEMENT</SMALL> </B>(this
&#147;<B><I>Agreement</I></B>&#148;), dated as of September&nbsp;5, 2023, is entered into between <B>L<SMALL>EGALZOOM</SMALL>.C<SMALL>OM</SMALL>, I<SMALL>NC</SMALL>.</B>, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), and LucasZoom,
LLC, a Delaware limited liability company (the &#147;<B><I>Seller</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>R<SMALL>ECITALS</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, the Seller is the beneficial owner of shares of the Company&#146;s common stock, $0.001
par value per share (the &#147;<B><I>Common Stock</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, the Seller desires
to sell, and the Company desires to repurchase, certain shares of the Common Stock on the terms and subject to the conditions set forth herein (the &#147;<B><I>Transaction</I></B>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, the Seller proposes to sell through an underwritten public offering (the
&#147;<B><I>Secondary Offering</I></B>&#148;) registered with the Securities and Exchange Commission certain other shares of Common Stock owned by the Seller. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>A<SMALL>GREEMENT</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>N<SMALL>OW</SMALL>, T<SMALL>HEREFORE</SMALL></B><SMALL></SMALL>, in consideration of the premises, and of the representations,
warranties, covenants and agreements set forth herein, the parties agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>C<SMALL>ERTAIN</SMALL> D<SMALL>EFINITIONS</SMALL> A<SMALL>ND</SMALL> C<SMALL>ONSTRUCTION</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;1.1</B> <B><U>Certain Definitions</U></B>. As used in this Agreement, the following terms have the
meanings set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Affiliate</I></B>&#148; of any particular Person means any other Person controlling,
controlled by or under common control with such particular Person. For the purposes of this definition, &#147;<B><I>control</I></B>&#148; means the possession, directly or indirectly, of the power to direct the management and policies of a Person
whether through the ownership of voting securities, Contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Business Day</I></B>&#148; means any day
except Saturday, Sunday or any other day on which commercial banks in New York, New York are authorized or required by Law to be closed. Any event the scheduled occurrence of which would fall on a day that is not a Business Day shall be deferred
until the next succeeding Business Day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Contract</I></B>&#148; means any written or legally binding oral contract, agreement or other legally binding instrument,
including any note, bond, mortgage, deed, indenture, commitment, undertaking, promise, lease, sublease, license, sublicense, purchase order or joint venture or any other enforceable arrangement or agreement to which the applicable Person is a party
or by which the applicable Person or any of its properties or assets is bound, in each case as amended, restated, extended, supplemented, waived or otherwise modified in writing to date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>FINRA</I></B>&#148; means Financial Industry Regulatory Authority. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Governmental Body</I></B>&#148; means any foreign, federal, state,
commonwealth, provincial, local or other court, governmental authority, tribunal, commission or regulatory body or self-regulatory body (including any securities exchange), or any political or other subdivision, department, agency or branch of any
of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Law</I></B>&#148; means any law, statute, treaty, common law, code, ordinance, rule, regulation, or
other requirement (including any policy or interpretation having the force of law) enacted, promulgated, or imposed by any Governmental Body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B><I>&#147;Per Share Purchase Price</I></B>&#148; means the price per share payable by the Underwriters to the Seller pursuant to the
Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Person</I></B>&#148; means any individual, general or limited partnership, corporation, limited
liability company, business trust, joint stock company, trust, unincorporated organization, joint venture, firm, association or other entity or organization (whether or not a legal entity), including any Governmental Body (or any department, agency,
or political subdivision thereof) and shall include, for the avoidance of doubt, any party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Proceeding</I></B>&#148;
means any claim, action, demand, suit, proceeding, binding mediation or arbitration, demand, charge, subpoena, complaint or indictment, including before any Governmental Body or authorized arbitrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B><I>&#147;Repurchase Shares</I></B>&#148; means the number of shares of Common Stock (rounded down to the nearest whole number, if
applicable) to be sold by the Seller and to be purchased by the Company hereunder, as determined in accordance with Section&nbsp;2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B><I>&#147;Total Shares&#148;</I></B> means the sum of the Underwritten Shares (as defined in the Underwriting Agreement) and the
Option Shares (as defined in the Underwriting Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Underwriters</I></B>&#148; means the sole underwriter or
several underwriters, as applicable, specified in the Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify">&#147;<B><I>Underwriting Agreement</I></B>&#148;
means the underwriting agreement by and among the Seller, the Company and the Underwriters to be entered into in connection with the Secondary Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;1.2</B> <B><U>Additional Definitions</U></B>. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;2.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Order</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;5.1(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Intended Tax Treatment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;4.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Repurchase Shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;2.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Seller</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Recitals</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Transfer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;4.2</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;1.3</B> <B><U>Headings</U></B>. The headings herein are included for
convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;1.4</B> <B><U>Construction</U></B>. Unless the context
otherwise requires, as used in this Agreement: (i) &#147;<B><I>or</I></B>&#148; is not exclusive; (ii) &#147;<B><I>including</I></B>&#148; and its variants mean &#147;<B><I>including, without limitation</I></B>&#148; and its variants;
(iii)&nbsp;words defined in the singular have the parallel meaning in the plural and vice versa; (iv)&nbsp;references to &#147;<B><I>written</I></B>&#148; or &#147;<B><I>in writing</I></B>&#148; include in visual electronic form; (v)&nbsp;words of
one gender shall be construed to apply to each gender; (vi)&nbsp;the term &#147;<B><I>Section</I></B>&#148; refers to the specified Section of this Agreement; (vii)&nbsp;the terms &#147;<B><I>Dollars</I></B>&#148; and &#147;<B><I>$</I></B>&#148;
mean United States Dollars; and (viii)&nbsp;the word &#147;<B><I>extent</I></B>&#148; in the phrase &#147;<B><I>to the extent</I></B>&#148; shall mean the degree to which a subject or other thing extends and such phrase shall not mean simply
&#147;<B><I>if</I></B>&#148;. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>T<SMALL>HE</SMALL> T<SMALL>RANSACTION</SMALL>; T<SMALL>HE</SMALL> C<SMALL>LOSING</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;2.1</B> <B><U>The Transaction</U></B>. On the terms and subject to the conditions set forth herein, at the
Closing (as defined below), the Seller shall sell and the Company shall purchase from the Seller either (a)&nbsp;if the Total Shares is less than or equal to 14,950,000 shares of Common Stock, 4,050,000 shares of Common Stock, less such number of
shares of Common Stock (rounded down to the nearest whole number) so that the maximum aggregate purchase price of such shares under this clause (a)&nbsp;does not exceed $45,064,116, or (b)&nbsp;if the Total Shares, together with any other shares of
Common Stock the Seller agrees to sell on the date hereof (&#147;<B><I>Additional Sales</I></B>&#148;), is greater than 14,950,000 shares of Common Stock, a number of shares of Common Stock (rounded down to the nearest whole number) equal to
$45,064,116 divided by the Per Share Purchase Price, in each case at the Per Share Purchase Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;2.2</B> <B><U>The Closing</U></B>. Unless otherwise mutually agreed in writing between the Company and the
Seller, the closing of the Transaction (the &#147;<B><I>Closing</I></B>&#148;) shall take place at the offices of Cooley LLP, 1333 2nd Street, Suite 400, Santa Monica, California 90401, on the same day as the initial closing of the Secondary
Offering contemplated by the Underwriting Agreement, or at such other place or time as the parties may agree in writing, subject to satisfaction of the conditions in Article V hereof (the &#147;<B><I>Closing Date</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;2.3</B> <B><U>Deliveries at the Closing</U></B>. At or prior to the Closing, (a)&nbsp;the Seller shall
deliver to the Company, or as otherwise instructed by the Company, the Repurchase Shares (b)&nbsp;the Company shall deliver to the Seller, or as otherwise instructed by the Seller, a dollar amount equal to the product of the Per Share Purchase Price
and the Repurchase Shares by wire transfer of immediately available funds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;2.4</B> <B><U>Other
Deliveries by the Seller</U></B>. At or prior to the Closing, the Seller shall deliver to the Company a valid U.S. Internal Revenue Service Form <FONT STYLE="white-space:nowrap">W-9</FONT> or <FONT STYLE="white-space:nowrap">W-8,</FONT> as
applicable, including all relevant attachments (or any such successor form or other applicable form or statement specified by the Treasury Department regulations in lieu thereof), and all other documents requested by the Company per Section&nbsp;4.1
hereof. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>R<SMALL>EPRESENTATIONS</SMALL> A<SMALL>ND</SMALL> W<SMALL>ARRANTIES</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;3.1</B> <B><U>Representations and Warranties of the Seller</U></B>. The Seller represents and warrants to
the Company: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(a)</B> <B><U>Organization</U></B>. The Seller has been duly formed and is validly existing as a limited liability
company and is in good standing under the laws of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(b)</B> <B><U>Power and Authority</U></B>. Except for
such consents, approvals, authorizations and orders as may be required under any state securities, blue sky or antifraud laws or FINRA in connection with the purchase of the Repurchase Shares by the Company, all consents, approvals, authorizations
and orders necessary for the execution and delivery by the Seller of this Agreement and for the sale and delivery of the Repurchase Shares to the Company hereunder have been obtained, except for such consents,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
approvals, authorizations or orders as would not adversely affect in any material respect the Seller&#146;s ability to perform its obligations hereunder; and the Seller has full right, power and
authority to enter into this Agreement and to sell, assign, transfer and deliver the Repurchase Shares; this Agreement has been duly authorized, executed and delivered by the Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(c)</B> <B><U>Title to Shares</U></B>. The Seller has, or will have immediately prior to the Closing Date, good and valid title to
the Repurchase Shares, free and clear of all liens, encumbrances, equities or adverse claims. At the Closing, the Seller&#146;s entire right, title and interest in and to Repurchase Shares shall be conveyed to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(d)</B> <B><U>No Conflict</U></B>. The execution, delivery and performance by the Seller of this Agreement and its obligations
hereunder and the consummation by the Seller of the Transaction will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any
lien, charge or encumbrance upon any property or assets of the Seller pursuant to, any indenture, mortgage, deed of trust, loan agreement or other material Contract to which the Seller is a party, (ii)&nbsp;result in any violation of the provisions
of the certificate of formation or limited liability company agreement of the Seller or (iii)&nbsp;result in the violation of any law or statute or any order, rule or regulation of any court or arbitrator or governmental or regulatory agency having
jurisdiction over the Seller or the property of the Seller, except in the cases of clauses (i)&nbsp;and (iii), as would not, individually or in the aggregate, adversely affect in any material respect the Seller&#146;s ability to perform its
obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(e)</B> <B><U>Sophistication of Seller; Receipt of Information</U></B>. The Seller has such knowledge,
sophistication and experience in financial and business matters that the Seller is capable of evaluating the merits and risks of entering into this Agreement and the consummation of the Transaction. The Seller has or has access to all information
that it believes to be necessary, sufficient or appropriate in connection with the Transaction. The Seller has previously undertaken such independent investigation of the Company as in its judgment is appropriate to make an informed decision with
respect to the Transaction, and the Seller has made its own decision to consummate the Transaction based on its own independent review and consultations with such investment, legal, tax, accounting and other advisers as it has deemed necessary and
without reliance on any express or implied representation or warranty of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(f)</B> <B><U>No Broker&#146;s Fees or
Transactions</U></B>. The Seller is not a party to any contract, agreement or understanding with any Person that would give rise to a valid claim against the Company for an investment banking fee, commission, finder&#146;s fee or like payment in
connection with the Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(g)</B> <B><U>Tax Matters</U></B>. The Seller will own, actually and to the Seller&#146;s
knowledge, constructively, less than 50% of the Company&#146;s Common Stock immediately after the Closing and the closing of the Secondary Offering and the closing of any Additional Sales, and the Seller&#146;s percentage ownership, actual and to
the Seller&#146;s knowledge, constructive, of the Company&#146;s Common Stock immediately after the Closing and the closing of the Secondary Offering and the closing of any Additional Sales will be less than 80% of the Seller&#146;s percentage
ownership, actual and to the Seller&#146;s knowledge, constructive, of the Company&#146;s Common Stock immediately before the Closing and the closing of the Secondary Offering and the closing of any Additional Sales, in each case within the meaning
of Section&nbsp;302 of the Code. The Seller is, and will be immediately before the Closing, disregarded as an entity separate from Lucazoom S.&agrave; r.l., a private limited liability company incorporated in Luxembourg, for U.S. federal and
applicable state and local income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(h)</B> <B><U>No Other Representations or Warranties</U></B>. The Seller (or any
other Person on behalf of the Seller) makes no other representations and warranties other than those expressly set forth in this Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;3.2</B> <B><U>Representations and Warranties of the Company</U></B>. The Company represents and warrants
to the Seller: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(a)</B> <B><U>Organization</U></B>. The Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(b)</B> <B><U>Power and
Authority</U></B>. Except for such consents, approvals, authorizations and orders as may be required under any state securities, blue sky or antifraud laws or FINRA in connection with the sale of Repurchase Shares by the Seller, all consents,
approvals, authorizations and orders necessary for the execution and delivery by the Company of this Agreement and for the purchase of Repurchase Shares by the Company hereunder have been obtained, except for such consents, approvals, authorizations
or orders as would not adversely affect in any material respect the Company&#146;s ability to perform its obligations hereunder; and the Company has full right, power and authority to enter into this Agreement and to purchase the Repurchase Shares
from the Seller; this Agreement has been duly authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(c)</B> <B><U>No
Conflict</U></B>. The execution, delivery and performance by the Company of this Agreement and its obligations hereunder and the consummation by the Company of the Transaction will not (i)&nbsp;conflict with, or result in a breach or violation of
any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other material Contract to which the Company is a party, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company or (iii)&nbsp;result in the violation of any
law or statute or any order, rule or regulation of any court or arbitrator or governmental or regulatory agency having jurisdiction over the Company or the property of the Company, except in the cases of clauses (i)&nbsp;and (iii), as would not,
individually or in the aggregate, adversely affect in any material respect the Company&#146;s ability to perform its obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(d)</B> <B><U>No Broker&#146;s Fees</U></B>. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or
understanding with any Person that would give rise to a valid claim against the Seller for an investment banking fee, commission, finder&#146;s fee or like payment in connection with the Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(e)</B> <B><U>No Other Representations or Warranties</U></B>. The Company (or any other Person on behalf of the Company) makes no
other representations and warranties other than those expressly set forth in this Section&nbsp;3.2. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>C<SMALL>OVENANTS</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section&nbsp;4.1 <U>Further Assurances</U></B>. The parties agree to use commercially reasonable efforts to execute and deliver, or
cause to be executed and delivered, such further instruments or documents or take such other action (including providing instructions to the Company&#146;s transfer agent and registrar or the Depository Trust Company or other custodians of the
Repurchase Shares) as may be reasonably necessary (or as reasonably requested by another party) to consummate the Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;4.2</B> <B><U>Withholding</U></B>. The Company shall be entitled to deduct and withhold from the purchase
price any amounts required to be deducted or withheld under applicable Law; <I>provided</I> that, except to the extent that the necessity for any such deduction or withholding arises by reason of the failure of the Seller to deliver the
documentation required under Section&nbsp;2.4, the Company shall notify the Seller of the Company&#146;s intention to deduct or withhold such amounts and the reason therefor and to use commercially reasonable efforts to cooperate with the Seller to
reduce the amount of, or eliminate the necessity for, such deduction or withholding. To the extent that amounts are so deducted or withheld, such amounts shall be remitted to the proper Governmental Body and be treated for all purposes of this
Agreement as having been paid to the Seller in respect of which such deduction or withholding was made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;4.3</B> <B><U>Tax Treatment</U></B>. The parties hereto agree to treat, for U.S. federal income tax
purposes, the Transaction as distributions in part or full payment in exchange for the Repurchase Shares </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
pursuant to Section&nbsp;302(a) of the Code, and not as distributions of property to which Section&nbsp;301 of the Code applies (the &#147;<B><I>Intended Tax Treatment</I></B>&#148;), unless
otherwise required by a change in applicable Law after the date hereof or pursuant to a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code; <I>provided</I>, that if there is an inaccuracy in Seller&#146;s representation
in the first sentence of Section&nbsp;3.1(g), the parties will cooperate in good faith to determine whether the Transaction qualifies for the Intended Tax Treatment; <I>provided,</I> that the Company shall keep the Seller reasonably informed of the
progress of any audit or similar proceeding related to the Intended Tax Treatment and shall not settle or compromise any such audit or proceeding without the prior written consent of the Seller, such consent not be unreasonably withheld, conditioned
or delayed. The Seller shall indemnify the Company against any withholding taxes (and any penalties and interest thereon, and reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses) incurred
by the Company in connection with the Company&#146;s failure to deduct or withhold the proper amount of tax from the purchase price paid to the Seller as a result of the Intended Tax Treatment. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>C<SMALL>ONDITIONS</SMALL>
T<SMALL>O</SMALL> C<SMALL>LOSING</SMALL>; T<SMALL>ERMINATION</SMALL> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;5.1</B> <B><U>Conditions to
Each Party&#146;s Obligation to Consummate the Transaction</U></B>. The respective obligation of each party hereto to consummate the Transaction is subject to the satisfaction or waiver of the following conditions by all parties: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(a)</B> <B><U>No Injunction</U></B>. No judgment, injunction, decree or other legal restraint (each, an
&#147;<B><I>Order</I></B>&#148;) prohibiting the consummation of the Transaction shall have been issued by any Governmental Body and be continuing in effect, there shall be no pending Proceeding commenced by a Governmental Body seeking an Order that
would prohibit the Transaction, and the consummation of the Transaction shall not have been prohibited or rendered illegal under any applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(b)</B> <B><U>Execution of the Closing</U></B>. The consummation of the transactions contemplated by the Underwriting Agreement shall
have occurred prior to or simultaneously with the Closing herewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;5.2</B> <B><U>Conditions to the
Seller&#146;s Obligation to Consummate the Transaction</U></B>. The obligations of the Seller to consummate the Transaction are subject to the satisfaction or waiver of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(a)</B> <B><U>Representations and Warranties</U></B>. The representations and warranties of the Company set forth in Section&nbsp;3.2
shall be true and correct as of the date hereof and as of the Closing Date as if made on and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such
representation and warranty shall be true and correct as of such earlier date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(b)</B> <B><U>Covenants</U></B>. Each of the
covenants and agreements of the Company contained in this Agreement that are to be performed at or prior to the Closing shall have been duly performed in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;5.3</B> <B><U>Conditions to the Company&#146;s Obligation to Consummate the Transaction</U></B>. The
obligation of the Company to consummate the Transaction is subject to the satisfaction or waiver of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(a)</B> <B><U>Representations and Warranties</U></B>. The representations and warranties of the Seller set forth in Section&nbsp;3.1
shall be true and correct as of the date hereof and as of the Closing Date as if made on and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such
representation and warranty shall be true and correct as of such earlier date). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(b)</B> <B><U>Covenants</U></B>. Each of the covenants and agreements of the Seller
contained in this Agreement that are to be performed at or prior to the Closing shall have been duly performed in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;5.4</B> <B><U>Automatic Termination</U></B>. Notwithstanding anything contained herein to the contrary, if
the Underwriting Agreement is not executed and delivered by the parties hereto within three (3)&nbsp;Business Days of the date hereof, this Agreement shall automatically terminate with no further action required by the parties. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>M<SMALL>ISCELLANEOUS</SMALL>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.1</B> <B><U>Notices</U></B>. All notices and other communications hereunder shall be in writing
and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to shall be given to (i)&nbsp;the Company at LegalZoom.com, Inc., 101 North Brand Boulevard, 11th Floor, Glendale,
California 91203; Attention: General Counsel at [***], with a copy to Cooley LLP 1333 2nd Street, Suite 400, Santa Monica, California 90401; Attention: Thomas Hopkins at [***], Jodie Bourdet at [***] and Logan Tiari at [***]; and (ii)&nbsp;the
Seller at c/o Permira Advisers LLC, 3000 Sand Hill Road, Building 1, Suite 170, Menlo Park, California 94025; Attention: Molly Breen Dirscherl at [***], with a copy to Fried, Frank, Harris, Shriver&nbsp;&amp; Jacobson LLP, One New York Plaza, New
York, New York 10004; Attention: Brian Mangino at [***] and Joshua Coleman at [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.2</B> <B><U>No
Third Party Beneficiaries</U></B>. This Agreement shall be binding upon and inure solely to the benefit of each party and its successors and permitted assigns, and nothing in this Agreement, express or implied, is intended to or shall be construed
to confer upon any other Person any legal or equitable rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement. This Agreement may be amended or terminated, and any provision of this Agreement may be waived, in
accordance with the terms hereof without the consent of any Person other than the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.3</B>
<B><U>Assignment</U></B>. Neither this Agreement nor any of the rights, interests or obligations hereunder may be assigned, delegated or otherwise transferred, in whole or in part, directly or indirectly, by operation of Law or otherwise (including
by merger, contribution, <FONT STYLE="white-space:nowrap">spin-off</FONT> or otherwise), by any of the parties without the prior written consent of the rest of the parties, and any purported assignment or delegation in contravention of this
Section&nbsp;6.3 shall be null and void and of no force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.4</B> <B><U>Prior Negotiations;
Entire Agreement</U></B>. This Agreement (including the documents and instruments referred to in this Agreement) constitutes the sole and entire agreement of the parties with respect to the subject matter contained herein and therein, and supersede
all other prior representations, warranties, understandings and agreements, both written and oral, with respect to such subject matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.5</B> <B><U>Governing Law; Submission to Jurisdiction; Waiver of Jury Trial</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(a)</B> This Agreement shall be interpreted, construed and governed by and in accordance with the internal Laws of the State of New
York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the Law of any jurisdiction other than those of the State of New York.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(b)</B> Each of the parties (i)&nbsp;consents to submit itself to the exclusive jurisdiction of the courts of the State of New
York located in the city and county of New York in any Proceeding arising out of or relating to this Agreement or if the subject matter jurisdiction over such Proceeding is vested exclusively in the federal courts of the United States of America,
the federal courts of the United States of America </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
located in the city and county of New York, (ii)&nbsp;agrees that all claims in respect of any such Proceeding may be heard and determined in any such court, (iii)&nbsp;agrees that it shall not
attempt to deny or defeat such jurisdiction by motion or other request for leave from any such court, (iv)&nbsp;agrees not to bring any Proceeding arising out of or relating to this Agreement (whether in contract, tort, common or statutory law,
equity or otherwise) in any other court and (v)&nbsp;agrees that a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment in any such Proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment
or in any other manner provided by applicable Law. Each of the parties waives any defense of inconvenient forum to the maintenance of any Proceeding brought in accordance with this Section&nbsp;6.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>(c)</B> EACH PARTY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF
ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.6</B> <B><U>Specific
Performance</U></B>. The Seller, without prejudice to any rights to judicial relief it may otherwise have, shall be entitled to seek equitable relief, including injunction and/or specific performance, in the event of any breach or threatened breach
of the provisions of this Agreement. The Company agrees that it will not oppose the granting of such relief on the basis that the Seller has an adequate remedy at law and that assuming the injunctive relief is obtained the Company will pay any fees
that the Seller may incur in enforcing this Agreement. The Company also agrees that it will not seek and agrees to waive any requirement for the securing or posting of a bond in connection with the Seller&#146;s seeking or obtaining such relief.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.7</B> <B><U>Counterparts</U></B>. This Agreement may be executed in one or more counterparts, each
of which shall be deemed to be an original and all of which, when taken together, shall be deemed to be one and the same agreement or document. A signed copy of this Agreement transmitted by facsimile, email or other means of electronic transmission
shall be deemed to have the same legal effect as delivery of an original executed copy of this Agreement for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.8</B> <B><U>Expenses</U></B>. Each party shall bear its own expenses incurred or to be incurred in
connection with the negotiation and execution of this Agreement and the consummation of the Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>Section</B><B></B><B>&nbsp;6.9</B> <B><U>Waivers and Amendments</U></B>. This Agreement may be amended, modified, superseded,
cancelled, renewed or extended, and the terms and conditions of this Agreement may be waived, only by a written instrument signed by the parties. No delay on the part of any party in exercising any right, power or privilege pursuant to this
Agreement shall operate as a waiver thereof, nor shall any waiver of the part of any party of any right, power or privilege pursuant to this Agreement, nor shall any single or partial exercise of any right, power or privilege pursuant to this
Agreement, preclude any other or further exercise thereof or the exercise of any other right, power or privilege pursuant to this Agreement. The rights and remedies provided pursuant to this Agreement are cumulative and are not exclusive of any
rights or remedies which any party otherwise may have at Law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>[S<SMALL>IGNATURE</SMALL> P<SMALL>AGES</SMALL> F<SMALL>OLLOW</SMALL>]
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>,
this Agreement is executed as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><B>SELLERS:</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><B>LucasZoom, LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:ARIAL" ALIGN="justify">/s/ Thomas Lafrance</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Thomas Lafrance</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Authorized Signatory</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> &#150; S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL>
A<SMALL>GREEMENT</SMALL>] </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:ARIAL" ALIGN="justify"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>,
this Agreement is executed as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><B>COMPANY:</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><B>L<SMALL>EGALZOOM</SMALL>.C<SMALL>OM</SMALL>, I<SMALL>NC</SMALL>.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:ARIAL" ALIGN="justify">/s/ Dan Wernikoff</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Dan Wernikoff</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> &#150; S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL>
A<SMALL>GREEMENT</SMALL>] </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lz-20230905.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 1:19:45 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:lz="http://leg.com/20230905"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://leg.com/20230905"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lz-20230905_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lz-20230905_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lz-20230905_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 1:19:45 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lz-20230905_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 1:19:45 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lz-20230905.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140309269504512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001286139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  05,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LegalZoom.com, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4752856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">101 North Brand Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">11th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Glendale<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">962-8600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LZ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d485281d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lz-20230905.xsd" xlink:type="simple"/>
    <context id="duration_2023-09-05_to_2023-09-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001286139</identifier>
        </entity>
        <period>
            <startDate>2023-09-05</startDate>
            <endDate>2023-09-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-09-05_to_2023-09-05">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-09-05_to_2023-09-05"
      id="Hidden_dei_EntityCentralIndexKey">0001286139</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-09-05_to_2023-09-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-09-05_to_2023-09-05">2023-09-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-09-05_to_2023-09-05">LegalZoom.com, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-09-05_to_2023-09-05">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-09-05_to_2023-09-05">001-35618</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-09-05_to_2023-09-05">95-4752856</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-09-05_to_2023-09-05">101 North Brand Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-09-05_to_2023-09-05">11th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-09-05_to_2023-09-05">Glendale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-09-05_to_2023-09-05">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-09-05_to_2023-09-05">91203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-09-05_to_2023-09-05">(323)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-09-05_to_2023-09-05">962-8600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-09-05_to_2023-09-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-09-05_to_2023-09-05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-09-05_to_2023-09-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-09-05_to_2023-09-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-09-05_to_2023-09-05">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-05_to_2023-09-05">LZ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-09-05_to_2023-09-05">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-09-05_to_2023-09-05">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ W8HK5P=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #=BBM7KY^2W^\    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" #=BBM7F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( -V**U=W6IXL9@0  #41   8
M      " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" #=BBM7GZ ;\+$"  #B#   #0              @ &J#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( -V**U>7BKL<P    !,"   +              "
M 88/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( -V**U<<.&7J/P$  #P"   /
M              "  6\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #=
MBBM7)!Z;HJT   #X 0  &@              @ ';$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #=BBM799!YDAD!  #/ P  $P
M            @ ' $@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"   *%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d485281d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d485281d8k.htm">d485281d8k.htm</File>
    <File>d485281dex101.htm</File>
    <File>d485281dex11.htm</File>
    <File>lz-20230905.xsd</File>
    <File>lz-20230905_lab.xml</File>
    <File>lz-20230905_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d485281d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d485281d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lz-20230905_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lz-20230905_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lz-20230905.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lz",
   "nsuri": "http://leg.com/20230905",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d485281d8k.htm",
      "contextRef": "duration_2023-09-05_to_2023-09-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d485281d8k.htm",
      "contextRef": "duration_2023-09-05_to_2023-09-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://leg.com//20230905/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-232599-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-232599-xbrl.zip
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M]Z[;Z9'SJPO2^:/]Z_G5QPYI7W_ZU.WUNM=7CX*Q^A0P_G[>^[5[]?'N^JI
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MP6UL% @.?%,BSZ]$JO6GX+75K&/"NELVY IC^. *6G8V*)=L2-T_A1AC&J5
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MPV$1XWNCTA8EL6>I8@@SQ$M@.4\>5*]O^CRJU#-@0[&1NQ68O8HJ#&A=[NR
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MLV6QN/KA;;',F^3W_#)Y72TS>-/IB^>__OZO7]6XR*]^^O'GGYZ]/R\F19O
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M#ER2NGS;5F(\QF[TE>5EWAMB@H8$0HS(Y_JT)GQ<0R:F3 E<"4@Q]ES#@9
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M;U]U]RO<+D4 R)#T\5-+^+G@T1&]@@HIYN!IE6V7=C4&1M!_%;](0G,8)KH
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MWM:X<SE83E=YJ,>=H"&[R@U7NY/6)F5G827)^VBLP77SK;%9Z$<4>2JF0)[
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M]Q;XS94%1:0_5%O<FN1W 90[E/_W'M.;SZ6I7&Q%GEIP*\A MJEU%V"P0M=
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M* W!Z!,,1TOZ*AH=R6A>A[5#46N%C/0?H'F8=JOP.FG,7I5*?U/XEY.CHY,
MJMMA@D93IQ8=-/0'**E*"]GS&<S^.S6>KOV0I#5#4,(3EX*%';*S:W0=HKV>
MT ??'WUCO^G'XN"W[E\"-(U3"!;Z<SP*K6>FK-,P:"4&] ;K62/>!)#GD<#H
M%CD"PGV8J<;#\JQ&)*Z6WT%_S>:M]K5%*57\.J1FPL\O6YG;B/N:@+I.L!^#
M!!I]><BBP1[T\>CXFX=[Y_M[)_N#CL1^QZ*G/;9>3,;0)"]E3(K@&? _'<R-
MDYJ4H*^9^*0&)G,@"%ER"9[" 4]*:<@20?*FGZ0AS%X$".?AT:/!'6FG\^>8
MA'CP)0EQI_*A;:,%1E0!\=K!_/QA"\"UL!#Y!+Y'U&6[#C].@.*.6J?5TAR
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M&X2CGM.8@?,N3DI8RGV,Y?K1A(POG3]^]%TD4&QQ:5L/>8;M"CR;PA0"PI)
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MLX]LI3:NU2'C#74HC&XK4$;[(I:YA71)B0C-<DQ(&G&X10)E03A0 '=)A++
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MN?F*U[]QV_34$25T*0V0"OCHS-L-AF#?;HO'FE">L%S7<G-"MTXI"A!;B]]
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M'('!HT9/R!^?IDC\3J,J[G"*FT?1RM4SO6/'^1O-H(V*VW&$B;_;4-CC)'B
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MPF<)#(%(\$J/=HXP<B;9M29:S(L?&H!Q3-:7&@ECNV<Y=DCDBDUQJ98)%,(
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MW>Z>NLYEJZW;[O1;O-EJ1@S]_ U02P,$%     @ W8HK5S8JH.Y[!@  N48
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M,3 Q+FAT;5!+ 0(4 Q0    ( -V**U=;<IJ+K:L  ):; P 0
M  "  4(]  !D-#@U,C@Q9&5X,3$N:'1M4$L! A0#%     @ W8HK5X#,%U0W
M P  *PL   \              ( !'>D  &QZ+3(P,C,P.3 U+GAS9%!+ 0(4
M Q0    ( -V**U<V*J#N>P8  +E&   3              "  8'L  !L>BTR
M,#(S,#DP-5]L86(N>&UL4$L! A0#%     @ W8HK5[[F)#B\!   *RP  !,
M             ( !+?,  &QZ+3(P,C,P.3 U7W!R92YX;6Q02P4&      8
,!@!X 0  &O@

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
